Affiliated/Scientific Publications

Acknowledging ERN RARE-LIVER in a publication adds to the prominence of the network and provides a chance for fruitful collaboration. Affiliated Scientific Publications involve as major contributors at least two Health Care Providers from two different Member States within the ERN and acknowledge the ERN.

Affiliated Scientific Publications

2024 -01

  • An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis
    Romée J A L M Snijders, Anna E C Stoelinga, Tom J G Gevers, Simon Pape, Maaike Biewenga, Maarten E Tushuizen, Robert C Verdonk, Hendrik J M de Jonge, Jan Maarten Vrolijk, Sjoerd F Bakker, Thomas Vanwolleghem, Ynto S de Boer, Martine A M C Baven Pronk, Ulrich Beuers, Adriaan J van der Meer, Nicole M F van Gerven, Marijn G M Sijtsma, Brechje C van Eijck, Manon C van IJzendoorn, Margot van Herwaarden, Floris F van den Brand, Kerem Sebib Korkmaz, Aad P van den Berg, Maureen M J Guichelaar, Amar D Levens, Bart van Hoek , Joost P H Drenth; Dutch Autoimmune Hepatitis Working Group
    J Hepatol. 2024 Apr;80(4):576-585. DOI: 10.1016/j.jhep.2023.11.032

  • Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis
    Francesca Colapietro, Patrick Maisonneuve, Ellina Lytvyak, Ulrich Beuers, Robert C. Verdonk, Adriaan J. van der Meer, Bart van Hoek, Sjoerd D. Kuiken, Johannes T. Brouwer, Paolo Muratori, Alessio Aghemo, Francesco Carella, Ad P. van den Berg, Kalliopi Zachou, George N. Dalekos, Daniel E. Di Zeo-Sánchez, Mercedes Robles, Raul J. Andrade, Aldo J. Montano-Loza, Floris F. van den Brand, Charlotte D. Slooter, Guilherme Macedo, Rodrigo Liberal, Ynto S. de Boer, Ana Lleo
    Journal of Hepatology Volume 80, Issue 1, January 2024, Pages 53-61, doi.org/10.1016/j.jhep.2023.09.010

  • New Position Paper: Expert management of congenital portosystemic shunts and their complications

    Valérie Anne McLin, Stéphanie Franchi-Abella, Timothée Brütsch, Atessa Bahadori, Valeria Casotti,
    Jean de Ville de Goyet, Grégoire Dumery, Emmanuel Gonzales, Florent Guérin,
    Sebastien Hascoet, Nigel Heaton, Béatrice Kuhlmann, Frédéric Lador, Virginie Lambert, Paolo Marra,
    Aurélie Plessier, Alberto Quaglia, Anne-Laure Rougemont, Laurent Savale, Moinak Sen Sarma,
    Olivier Sitbon, Riccardo Antonio Superina, Hajime Uchida, Mirjam van Albada,
    Hubert Petrus Johannes van der Doef, Valérie Vilgrain, Julie Wacker, Nitash Zwaveling,
    Dominique Debray, Barbara Elisabeth Wildhaber

    Published: October 19, 2023 DOI:https://doi.org/10.1016/j.jhepr.2023.100933
    REVIEW| VOLUME 6, ISSUE 1, 100933, JANUARY 2024

  • PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease
    Lorenz Kocheise, Ignazio Piseddu, Joscha Vonderlin, Eric T Tjwa, Gustav Buescher, Lucy Meunier, Pia Goeggelmann, Francesca Fianchi, Jérôme Dumortier, Mar Riveiro Barciela, Tom J G Gevers, Benedetta Terziroli Beretta-Piccoli, Maria-Carlota Londoño, Sona Frankova, Thomas Roesner, Vincent Joerg, Constantin Schmidt, Fabian Glaser, Jan P Sutter, Thorben W Fründt, Ansgar W Lohse, Samuel Huber, Johann von Felden, Marcial Sebode, Kornelius Schulze
    Front Immunol. 2024 Jan 24:15:1369747. doi: 10.3389/fimmu.2024.1369747.

2023-12

  • ∆4-3-oxo-5β-reductase deficiency: favorable outcome in 16 patients treated with cholic acid
    Antoine Gardin, Mathias Ruiz, Jan Beime, Mara Cananzi, Margarete Rathert, Barbara Rohmer, Enke Grabhorn, Marion Almes, Veena Logarajah, Luis Peña-Quintana, Thomas Casswall, Amaria Darmellah-Remil, Ana Reyes-Domínguez, Emna Barkaoui, Loreto Hierro, Carolina Baquero-Montoya, Ulrich Baumann, Björn Fischler, Emmanuel Gonzales, Anne Davit-Spraul, Sophie Laplanche, Emmanuel Jacquemin
    Orphanet J Rare Dis. 2023; 18: 383. Published online 2023 Dec 7. doi: 10.1186/s13023-023-02984-z

  • A major research gap: The use of anticoagulants in cirrhosis.
    Senzolo M, Garcia-Pagan JC.
    J Hepatol. 2023 Dec;79(6):1566-1570. doi: 10.1016/j.jhep.2023.06.001. Epub 2023 Jun 10.

  • Any role for transarterial radioembolization in unresectable intrahepatic cholangiocarcinoma in the era of advanced systemic therapies?
    Alessandra Elvevi, Alice Laffusa, Federica Elisei, Sabrina Morzenti, Luca Guerra, Antonio Rovere, Pietro Invernizzi, Sara Massironi
    World J Hepatol. 2023 Dec 27; 15(12): 1284–1293. Published online 2023 Dec 27. doi: 10.4254/wjh.v15.i12.1284
    PMCID: PMC10784807

  • Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma
    Julien Calderaro, Narmin Ghaffari Laleh, Qinghe Zeng, Pascale Maille, Loetitia Favre, Anaïs Pujals, Christophe Klein, Céline Bazille, Lara R. Heij, Arnaud Uguen, Tom Luedde, Luca Di Tommaso, Aurélie Beaufrère, Augustin Chatain, Delphine Gastineau, Cong Trung Nguyen, Hiep Nguyen-Canh, Khuyen Nguyen Thi, Viviane Gnemmi, Rondell P. Graham, Frédéric Charlotte, Dominique Wendum, Mukul Vij, Daniela S. Allende, Federico Aucejo, Alba Diaz, Benjamin Rivière, Astrid Herrero, Katja Evert, Diego Francesco Calvisi, Jérémy Augustin, Wei Qiang Leow, Howard Ho Wai Leung, Emmanuel Boleslawski, Mohamed Rela, Arnaud François, Anthony Wing-Hung Cha, Alejandro Forner, Maria Reig, Manon Allaire, Olivier Scatton, Denis Chatelain, Camille Boulagnon-Rombi, Nathalie Sturm, Benjamin Menahem, Eric Frouin, David Tougeron, Christophe Tournigand, Emmanuelle Kempf, Haeryoung Kim, Massih Ningarhari, Sophie Michalak-Provost, Purva Gopal, Raffaele Brustia, Eric Vibert, Kornelius Schulze, Darius F. Rüther, Sören A. Weidemann, Rami Rhaiem, Jean-Michel Pawlotsky, Xuchen Zhang, Alain Luciani, Sébastien Mulé, Alexis Laurent, Giuliana Amaddeo, Hélène Regnault, Eleonora De Martin, Christine Sempoux, Pooja Navale, Maria Westerhoff, Regina Cheuk-Lam Lo, Jan Bednarsch, Annette Gouw, Catherine Guettier, Marie Lequoy, Kenichi Harada, Pimsiri Sripongpun, Poowadon Wetwittayaklang, Nicolas Loménie, Jarukit Tantipisit, Apichat Kaewdech, Jeanne Shen, Valérie Paradis, Stefano Caruso, Jakob Nikolas Kather
    Nat Commun. 2023; 14: 8290. Published online 2023 Dec 14. doi: 10.1038/s41467-023-43749-3

  • Evaluation of Tofacitinib in Primary Sclerosing Cholangitis and Associated Colitis: A Multicenter, Retrospective Study.
    Schregel I, Ramos GP, Ioannou S, Culver E, Färkkilä M, Schramm C; International PSC Study Group.
    Clin Gastroenterol Hepatol. 2023 Dec;21(13):3448-3450.e3. doi: 10.1016/j.cgh.2023.01.014. Epub 2023 Jan 31.

  • Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA.
    Hansen BE, Vandriel SM, Vig P, Garner W, Mogul DB, Loomes KM, Piccoli DA, Rand EB, Jankowska I, Czubkowski P, Gliwicz-Miedzińska D, Gonzales EM, Jacquemin E, Bouligand J, D’Antiga L, Nicastro E, Arnell H, Fischler B, Sokal É, Demaret T, Siew S, Stormon M, Karpen SJ, Romero R, Ebel NH, Feinstein JA, Roberts AJ, Evans HM, Sundaram SS, Chaidez A, Hardikar W, Shankar S, Fischer RT, Lacaille F, Debray D, Lin HC, Jensen MK, Jaramillo C, Karthikeyan P, Indolfi G, Verkade HJ, Larson-Nath C, Quiros-Tejeira RE, Valentino PL, Rogalidou M, Dezsőfi A, Squires JE, Schwarz K, Calvo PL, Bernabeu JQ, Zizzo AN, Nebbia G, Bulut P, Santos-Silva E, Fawaz R, Nastasio S, Karnsakul W, Tamara ML, Busoms CM, Kelly D, Sandahl TD, Jimenez-Rivera C, Banales JM, Mujawar Q, Li LT, She H, Wang JS, Kim KM, Oh SH, Sanchez MC, Cavalieri ML, Lee WS, Hajinicolaou C, Lertudomphonwanit C, Waisbourd-Zinman O, Arikan C, Alam S, Carvalho E, Melere M, Eshun J, Önal Z, Desai DM, Wiecek S, Pinto RB, Wolters VM, Garcia J, Beretta M, Kerkar N, Brecelj J, Rock N, Lurz E, Blondet N, Shah U, Thompson RJ, Kamath BM; Global ALagille Alliance (GALA) Study Group.
    Hepatology. 2023 Dec 25. doi: 10.1097/HEP.0000000000000727.

  • Predictors of 6-year event-free survival in Alagille syndrome patients treated with maralixibat, an ileal bile acid transporter inhibitor
    Ronald J. Sokol, Emmanuel M. Gonzales, Binita M. Kamath, Alastair Baker, Pamela Vig, Douglas B. Mogul, Will Garner, Bettina E. Hansen, Emmanuel Jacquemin, Richard J. Thompson
    Hepatology. 2023 Dec; 78(6): 1698–1710. Published online 2023 Jun 7. doi: 10.1097/HEP.0000000000000502

  • The genetics of portal hypertension: Recent developments and the road ahead.
    Shalaby S, Ronzoni L, Hernandez-Gea V, Valenti L.
    Liver Int. 2023 Dec;43(12):2592-2603. doi: 10.1111/liv.15732. Epub 2023 Sep 18.

2023-11

  • EASL-ERN position paper on liver involvement in patients with Fontan-type circulation.
    Téllez L, Payancé A, Tjwa E, Del Cerro MJ, Idorn L, Ovroutski S, De Bruyne R, Verkade HJ, De Rita F, de Lange C, Angelini A, Paradis V, Rautou PE, García-Pagán JC.
    J Hepatol. 2023 Nov;79(5):1270-1301. doi: 10.1016/j.jhep.2023.07.013.

  • Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.
    Kowdley KV, Bowlus CL, Levy C, Akarca US, Alvares-da-Silva MR, Andreone P, Arrese M, Corpechot C, Francque SM, Heneghan MA, Invernizzi P, Jones D, Kruger FC, Lawitz E, Mayo MJ, Shiffman ML, Swain MG, Valera JM, Vargas V, Vierling JM, Villamil A, Addy C, Dietrich J, Germain JM, Mazain S, Rafailovic D, Taddé B, Miller B, Shu J, Zein CO, Schattenberg JM; ELATIVE Study Investigators’ Group.
    N Engl J Med. 2023 Nov 13. doi: 10.1056/NEJMoa2306185.

  • FibroMeter scores are predictive noninvasive markers of advanced and significant liver fibrosis in patients with chronic viral hepatitis or metabolic dysfunction-associated steatotic liver disease
    Pinelopi Arvaniti, George Giannoulis, Vasiliki Lygoura, Nikolaos K. Gatselis, Stella Gabeta, Eirini Rigopoulou, George K. Koukoulis, Kalliopi Zachou, George N. Dalekos
    Ann Gastroenterol. 2023 Nov-Dec; 36(6): 661–669. Published online 2023 Nov 3. doi: 10.20524/aog.2023.0841

  • Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)-A European Society of Organ Transplantation (ESOT) Consensus Statement.
    Carbone M, Della Penna A, Mazzarelli C, De Martin E, Villard C, Bergquist A, Line PD, Neuberger JM, Al-Shakhshir S, Trivedi PJ, Baumann U, Cristoferi L, Hov J, Fischler B, Hadzic NH, Debray D, D’Antiga L, Selzner N, Belli LS, Nadalin S.
    Transpl Int. 2023 Sep 29;36:11729. doi: 10.3389/ti.2023.11729. eCollection 2023.

  • Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severity.
    Tedbury PR, Manfredi C, Degenhardt F, Conway J, Horwath MC, McCracken C, Sorscher AJ, Moreau S, Wright C, Edwards C, Brewer J, Guarner J, de Wit E, Williamson BN, Suthar MS, Ong YT, Roback JD, Alter DN, Holter JC, Karlsen TH, Sacchi N, Romero-Gómez M, Invernizzi P, Fernández J, Buti M, Albillos A, Julià A, Valenti L, Asselta R, Banales JM, Bujanda L, de Cid R, Franke A; Severe COVID-19 GWAS group; Sarafianos SG, Hong JS, Sorscher EJ, Ehrhardt A.
    FASEB J. 2023 Nov;37(11):e23220. doi: 10.1096/fj.202300077R.

  • Predicting de-novo portal vein thrombosis after HCV eradication: A long-term competing risk analysis in the ongoing PITER cohort.
    Kondili LA, Zanetto A, Quaranta MG, Ferrigno L, Panetta V, Calvaruso V, Zignego AL, Brunetto MR, Raimondo G, Biliotti E, Ieluzzi D, Iannone A, Madonia S, Chemello L, Cavalletto L, Coppola C, Morisco F, Barbaro F, Licata A, Federico A, Cerini F, Persico M, Pompili M, Ciancio A, Piscaglia F, Chessa L, Giacometti A, Invernizzi P, Brancaccio G, Benedetti A, Baiocchi L, Gentile I, Coppola N, Nardone G, Craxì A, Russo FP; PITER Collaborating Investigators.
    United European Gastroenterol J. 2023 Nov 30. doi: 10.1002/ueg2.12496.

  • Splanchnic vein thrombosis associated with SARS-CoV-2 infection: A VALDIG case-control study
    Pierre Deltenre, Audrey Payancé, Laure Elkrief, Vincenzo La Mura, Florent Artru, Anna Baiges, Jean-Paul Cervoni, Louise China, Isabelle Colle, Elise Lemaitre, Bogdan Procopet, Dietmar Schiller, Christophe Bureau, Odile Goria, Isabelle Ollivier, Alexandre Nuzzo, Pierre-Emmanuel Rautou, Aurélie Plessier, for VALDIG, an EASL consortium
    JHEP Rep. 2023 Nov; 5(11): 100894. Published online 2023 Aug 22. doi: 10.1016/j.jhepr.2023.100894
    PMCID: PMC10570588

  • Vaccination practices in pediatric transplantation: A survey among member centers of the European reference network TransplantChild.
    Donà D, Bravo-Gallego LY, Remacha EF, Cananzi M, Gastaldi A, Canizalez JT, Stephenne X, Lacaille F, Lindemans C, Calore E, Galea N, Benetti E, Nachbaur E, Sandes AR, Teixeira A, Ferreira S, Klaudel-Dreszler M, Ackermann O, Boyer O, Espinosa L, Guereta LG, Sciveres M, Fischler B, Schwerk N, Neland M, Nicastro E, Dello Strologo L, Toporski J, Vainumae I, Rascon J, Urbonas V, Del Rosal T, López-Granados E, Perilongo G, Baker A, Vega PJ; ERN TransplantChild Healthcare Working Group.
    Pediatr Transplant. 2023 Nov;27(7):e14589. doi: 10.1111/petr.14589. Epub 2023 Aug 5.

2023-10

  • Expert management of congenital portosystemic shunts and their complications
    Valérie Anne McLin, Stéphanie Franchi-Abella, Timothée Brütsch, Atessa Bahadori, Valeria Casotti, Jean de Ville de Goyet, Grégoire Dumery, Emmanuel Gonzales, Florent Guérin, Sebastien Hascoet, Nigel Heaton, Béatrice Kuhlmann, Frédéric Lador, Virginie Lambert, Paolo Marra, Aurélie Plessier, Alberto Quaglia, Anne-Laure Rougemont, Laurent Savale, Moinak Sen Sarma, Olivier Sitbon, Riccardo Antonio Superina, Hajime Uchida, Mirjam van Albada, Hubert Petrus Johannes van der Doef, Valérie Vilgrain, Julie Wacker, Nitash Zwaveling, Dominique Debray, Barbara Elisabeth Wildhaber
    JHEP Rep. 2024 Jan; 6(1): 100933. Published online 2023 Oct 20. doi: 10.1016/j.jhepr.2023.100933

  • Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients.
    Murray SM, Pose E, Wittner M, Londoño MC, Schaub G, Cook J, Dimitriadis S, Meacham G, Irwin S, Lim Z, Duengelhoef P, Sterneck M, Lohse AW, Perez V, Trivedi P, Bhandal K, Mullish BH, Manousou P, Provine NM, Avitabile E, Carroll M, Tipton T, Healy S, Burra P, Klenerman P, Dunachie S, Kronsteiner B, Maciola AK, Pasqual G, Hernandez-Gea V, Garcia-Pagan JC, Lampertico P, Iavarone M, Gines P, Lütgehetmann M, Schulze Zur Wiesch J, Russo FP, Barnes E, Marjot T; OCTAVE Collaborative Group, PITCH study, and the EASL supported COVID-Hep vaccine network.
    J Hepatol. 2024 Jan;80(1):109-123. doi: 10.1016/j.jhep.2023.10.009. Epub 2023 Oct 19.

  • Maternal liver-related symptoms during pregnancy in primary sclerosing cholangitis
    Jeremy S. Nayagam, Tobias J. Weismüller, Piotr Milkiewicz, Karolina M. Wronka, Emil Bik, Christoph Schramm, Katja Fuessel, Taotao Zhou, Johannes Chang, Martti Färkkilä, Ylva Carlsson, Anastasia Lundman, Nora Cazzagon, Giorgia Corrà, Eirini Rigopoulou, George N. Dalekos, Aiva Lundberg Båve, Annika Bergquist, Karim Ben Belkacem, Marco Marzioni, Martina Mancinelli, Xavier Verhelst, Hanns-Ulrich Marschall, Michael A. Heneghan, Deepak Joshi, the International PSC Study Group (IPSCSG)
    JHEP Rep. 2024 Jan; 6(1): 100951. Published online 2023 Oct 31. doi: 10.1016/j.jhepr.2023.100951
    PMCID: PMC10711472

  • Mechanistic Insights into Eosinophilic Esophagitis: Therapies Targeting Pathophysiological Mechanisms
    Sara Massironi, Giacomo Mulinacci, Camilla Gallo, Alessandra Elvevi, Silvio Danese, Pietro Invernizzi, Edoardo Vespa
    Cells. 2023 Oct; 12(20): 2473. Published online 2023 Oct 18. doi: 10.3390/cells12202473

  • Outcomes of 38 patients with PFIC3: Impact of genotype and of response to ursodeoxycholic acid therapy
    Emmanuel Gonzales, Antoine Gardin, Marion Almes, Amaria Darmellah-Remil, Hanh Seguin, Charlotte Mussini, Stéphanie Franchi-Abella, Mathieu Duché, Oanez Ackermann, Alice Thébaut, Dalila Habes, Bogdan Hermeziu, Martine Lapalus, Thomas Falguières, Jean-Philippe Combal, Bernard Benichou, Sonia Valero, Anne Davit-Spraul, Emmanuel Jacquemin
    JHEP Rep. 2023 Oct; 5(10): 100844. Published online 2023 Jul 13. doi: 10.1016/j.jhepr.2023.100844
    PMCID: PMC10494458

  • Prevalence and significance of antimitochondrial antibodies in autoimmune hepatitis (AIH): Results from a large multicentre study of the International AIH Group.
    Gatselis NK, Zachou K, Loza AJM, Cançado ELR, Arinaga-Hino T, Muratori P, Efe C, Floreani A, Invernizzi P, Takahashi A, Takaki A, Beretta-Piccoli BT, van Hoek B, Lytvyak E, Guedes LV, Purnak T, Cazzagon N, Lygoura V, Arvaniti P, Rigopoulou EI, Muratori L, Dalekos GN; International Autoimmune Hepatitis Group.
    Eur J Intern Med. 2023 Oct;116:43-50. doi: 10.1016/j.ejim.2023.06.001. Epub 2023 Jun 10.

  • Therapeutic Challenges for Gastric Neuroendocrine Neoplasms: Take It or Leave It?
    Federica Cavalcoli, Camilla Gallo, Lorenzo Andrea Coltro, Emanuele Rausa, Paolo Cantù, Pietro Invernizzi, Sara Massironi
    Medicina (Kaunas) 2023 Oct; 59(10): 1757. Published online 2023 Oct 1. doi: 10.3390/medicina59101757

2023-09

  • Alpha-1 Antitrypsin Augmentation and the Liver Phenotype of Adults With Alpha-1 Antitrypsin Deficiency (Genotype Pi∗ZZ).
    Fromme M, Hamesch K, Schneider CV, Mandorfer M, Pons M, Thorhauge KH, Pereira V, Sperl J, Frankova S, Reichert MC, Benini F, Burbaum B, Kleinjans M, Amzou S, Rademacher L, Bewersdorf L, Verbeek J, Nevens F, Genesca J, Miravitlles M, Nuñez A, Schaefer B, Zoller H, Janciauskiene S, Waern J, Oliveira A, Maia L, Simões C, Mahadeva R, Fraughen DD, Trauner M, Krag A, Lammert F, Bals R, Gaisa NT, Aigner E, Griffiths WJ, Denk H, Teumer A, McElvaney NG, Turner AM, Trautwein C, Strnad P.
    Clin Gastroenterol Hepatol. 2024 Feb;22(2):283-294.e5. doi: 10.1016/j.cgh.2023.08.038. Epub 2023 Sep 15.

  • Autoimmune liver diseases and diabetes.
    Jensen AH, Ytting H, Winther-Sørensen M, Burisch J, Bergquist A, Gluud LL, Wewer Albrechtsen NJ.
    Eur J Gastroenterol Hepatol. 2023 Sep 1;35(9):938-947. doi: 10.1097/MEG.0000000000002594. Epub 2023 Jun 22.

  • Hepatic safety and efficacy of immunomodulatory drugs used in patients with autoimmune hepatitis.
    Terziroli Beretta-Piccoli B, Buescher G, Dalekos G, Zachou K, Geerts A, Semmo N, Kolev M, De Martin E, Janik MK, Madaleno J, Lalosevic Stojkovic M, Dumortier J, Vanwolleghem T, Schregel I, Steinmann S, Lacaille F, Sebode M.
    J Autoimmun. 2023 Sep 14;140:103113. doi: 10.1016/j.jaut.2023.103113.

  • Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: First report of the IAIHG retrospective registry.
    Slooter CD, van den Brand FF, Lleo A, Colapietro F, Lenzi M, Muratori P, Kerkar N, Dalekos GN, Zachou K, Lucena MI, Robles-Díaz M, Di Zeo-Sánchez DE, Andrade RJ, Montano-Loza AJ, Lytvyak E, Lissenberg-Witte BI, Maisonneuve P, Bouma G, Macedo G, Liberal R, de Boer YS; Dutch AIH Study Group; International Autoimmune Hepatitis Group; Dutch AIH Study Group and International Autoimmune Hepatitis Group.
    Hepatology. 2023 Sep 4. doi: 10.1097/HEP.0000000000000589.

  • Liver Histology Before Treatment Withdrawal in Autoimmune Hepatitis: Is It Time to Review the ESPGHAN Recommendations?
    Maggiore G, Bernard O, Mosca A, Jacquemin E.
    J Pediatr Gastroenterol Nutr. 2023 Sep 1;77(3):e62-e63. doi: 10.1097/MPG.0000000000003857. Epub 2023 Jun 12

  • Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement
    M. Carbone, A. Della Penna, C. Mazzarelli, E. De Martin, C. Villard, A. Bergquist, P. D. Line, J. M. Neuberger, S. Al-Shakhshir, P. J. Trivedi, U. Baumann, L. Cristoferi, J. Hov, B. Fischler, N. H. Hadzic, D. Debray, L. D’Antiga, N. Selzner, L. S. Belli, S. Nadalin
    Transpl Int. 2023; 36: 11729. Published online 2023 Sep 29. doi: 10.3389/ti.2023.11729

  • Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report
    Raúl J. Andrade, Guruprasad P. Aithal, Ynto S. de Boer, Rodrigo Liberal, Alexander Gerbes, Arie Regev, Benedetta Terziroli Beretta-Piccoli, Christoph Schramm, David E. Kleiner, Eleonora De Martin, Gerd A. Kullak-Ublick, Guido Stirnimann, Harshad Devarbhavi, John M. Vierling, Michael P. Manns, Marcial Sebode, Maria Carlota Londoño, Mark Avigan, Mercedes Robles-Diaz, Miren García-Cortes, Edmond Atallah, Michael Heneghan, Naga Chalasani, Palak J. Trivedi, Paul H. Hayashi, Richard Taubert, Robert J. Fontana, Sabine Weber, Ye Htun Oo, Yoh Zen, Anna Licata, M Isabel Lucena, Giorgina Mieli-Vergani, Diego Vergani, Einar S. Björnsson
    J Hepatol. Author manuscript; available in PMC 2023 Dec 21.

    Published in final edited form as: J Hepatol. 2023 Sep; 79(3): 853–866. Published online 2023 May 8. doi: 10.1016/j.jhep.2023.04.033

  • TIPS prevents further decompensation and improves survival in patients with cirrhosis and portal hypertension in an individual patient data meta-analysis.
    Larrue H, D’Amico G, Olivas P, Lv Y, Bucsics T, Rudler M, Sauerbruch T, Hernandez-Gea V, Han G, Reiberger T, Thabut D, Vinel JP, Péron JM, García-Pagán JC, Bureau C.
    J Hepatol. 2023 Sep;79(3):692-703. doi: 10.1016/j.jhep.2023.04.028. Epub 2023 May 2.

2023-08

  • Patient-reported quality of care in primary sclerosing cholangitis.
    Walmsley M, Tornai D, Cazzagon N, Leburgue A, Mrzljak A, Lenzen H, Carbone M, Madaleno J, Lleo A, Junge N, Schramm C, Bergquist A.
    Liver Int. 2023 Aug;43(8):1654-1662. doi: 10.1111/liv.15650. Epub 2023 Jun 13.

  • Pediatric and Adult Liver Disease in Alpha-1 Antitrypsin Deficiency.
    Ruiz M, Lacaille F, Schrader C, Pons M, Socha P, Krag A, Sturm E, Bouchecareilh M, Strnad P.
    Semin Liver Dis. 2023 Aug;43(3):258-266. doi: 10.1055/a-2122-7674. Epub 2023 Jul 4.

  • Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.
    Hirschfield GM, Shiffman ML, Gulamhusein A, Kowdley KV, Vierling JM, Levy C, Kremer AE, Zigmond E, Andreone P, Gordon SC, Bowlus CL, Lawitz EJ, Aspinall RJ, Pratt DS, Raikhelson K, Gonzalez-Huezo MS, Heneghan MA, Jeong SH, Ladrón de Guevara AL, Mayo MJ, Dalekos GN, Drenth JPH, Janczewska E, Leggett BA, Nevens F, Vargas V, Zuckerman E, Corpechot C, Fassio E, Hinrichsen H, Invernizzi P, Trivedi PJ, Forman L, Jones DEJ, Ryder SD, Swain MG, Steinberg A, Boudes PF, Choi YJ, McWherter CA; ENHANCE Study Group*.
    Hepatology. 2023 Aug 1;78(2):397-415. doi: 10.1097/HEP.0000000000000395. Epub 2023 Apr 6.

  • Splanchnic vein thrombosis associated with SARS-CoV-2 infection: A VALDIG case-control study.
    Deltenre P, Payancé A, Elkrief L, La Mura V, Artru F, Baiges A, Cervoni JP, China L, Colle I, Lemaitre E, Procopet B, Schiller D, Bureau C, Goria O, Ollivier I, Nuzzo A, Rautou PE, Plessier A; for VALDIG, an EASL consortium.
    JHEP Rep. 2023 Aug 22;5(11):100894. doi: 10.1016/j.jhepr.2023.100894. eCollection 2023 Nov.

  • Treatment responses and outcomes in patients with autoimmune hepatitis and concomitant features of non-alcoholic fatty liver disease
    Kalliopi Zachou, Kalliopi Azariadis, Ellina Lytvyak, Romée J.A.L.M. Snijders, Atsushi Takahashi, Nikolaos K. Gatselis, Mercedes Robles, Raul J. Andrade, Christoph Schramm, Ansgar W. Lohse, Atsushi Tanaka, Joost P.H. Drenth, Aldo J. Montano-Loza, George N. Dalekos, International Autoimmune Hepatitis Group (IAIHG)
    JHEP Rep. 2023 Aug; 5(8): 100778. Published online 2023 Apr 22. doi: 10.1016/j.jhepr.2023.100778

2023-07

  • Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain?
    Corpechot C, Lemoinne S, Soret PA, Hansen B, Hirschfield G, Gulamhusein A, Montano-Loza AJ, Lytvyak E, Pares A, Olivas I, Eaton JE, Osman KT, Schramm C, Sebode M, Lohse AW, Dalekos G, Gatselis N, Nevens F, Cazzagon N, Zago A, Russo FP, Floreani A, Abbas N, Trivedi P, Thorburn D, Saffioti F, Barkai L, Roccarina D, Calvaruso V, Fichera A, Delamarre A, Sobenko N, Villamil AM, Medina-Morales E, Bonder A, Patwardhan V, Rigamonti C, Carbone M, Invernizzi P, Cristoferi L, van der Meer A, de Veer R, Zigmond E, Yehezkel E, Kremer AE, Deibel A, Bruns T, Große K, Wetten A, Dyson JK, Jones D, Dumortier J, Pageaux GP, de Lédinghen V, Chazouillères O, Carrat F; Global & ERN Rare-Liver PBC Study Groups.
    Hepatology. 2024 Jan 1;79(1):39-48. doi: 10.1097/HEP.0000000000000529. Epub 2023 Jul 3.

  • Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis.
    Guerrero A, Campo LD, Piscaglia F, Scheiner B, Han G, Violi F, Ferreira CN, Téllez L, Reiberger T, Basili S, Zamora J, Albillos A; Baveno Cooperation: an EASL consortium.
    J Hepatol. 2023 Jul;79(1):69-78. doi: 10.1016/j.jhep.2023.02.023. Epub 2023 Feb 28.

  • Bleeding and Thrombotic Complications in Patients With Cirrhosis: A State-of-the-Art Appraisal.
    Rautou PE, Caldwell SH, Villa E.
    Clin Gastroenterol Hepatol. 2023 Jul;21(8):2110-2123. doi: 10.1016/j.cgh.2023.04.016. Epub 2023 Apr 28.

  • Etiology and Outcome of Adult and Pediatric Acute Liver Failure in Europe.
    Lenz D, Hørby Jørgensen M, Kelly D, Cardinale V, Geerts A, Gonçalves Costa I, Fichtner A, Garbade SF, Hegen B, Hilberath J, de Kleine R, Kupčinskas L, McLin V, Niesert M, Prado Gonzalez V, Sturm E, Staufner C, Tjwa E, Willemse J, Zecher BF, Larsen FS, Sebode M, Ytting H.
    J Pediatr Gastroenterol Nutr. 2023 Jul 1;77(1):115-120. doi: 10.1097/MPG.0000000000003777. Epub 2023 Mar 17.

  • Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma.
    Lapitz A, Azkargorta M, Milkiewicz P, Olaizola P, Zhuravleva E, Grimsrud MM, Schramm C, Arbelaiz A, O’Rourke CJ, La Casta A, Milkiewicz M, Pastor T, Vesterhus M, Jimenez-Agüero R, Dill MT, Lamarca A, Valle JW, Macias RIR, Izquierdo-Sanchez L, Pérez Castaño Y, Caballero-Camino FJ, Riaño I, Krawczyk M, Ibarra C, Bustamante J, Nova-Camacho LM, Falcon-Perez JM, Elortza F, Perugorria MJ, Andersen JB, Bujanda L, Karlsen TH, Folseraas T, Rodrigues PM, Banales JM.
    J Hepatol. 2023 Jul;79(1):93-108. doi: 10.1016/j.jhep.2023.02.027. Epub 2023 Mar 1.

  • Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival.
    Murillo Perez CF, Ioannou S, Hassanally I, Trivedi PJ, Corpechot C, van der Meer AJ, Lammers WJ, Battezzati PM, Lindor KD, Nevens F, Kowdley KV, Bruns T, Cazzagon N, Floreani A, Mason AL, Gulamhusein A, Ponsioen CY, Carbone M, Lleo A, Mayo MJ, Dalekos GN, Gatselis NK, Thorburn D, Verhelst X, Parés A, Londoño MC, Janssen HLA, Invernizzi P, Vuppalanchi R, Hirschfield GM, Hansen BE, Levy C; Global PBC Study Group.
    Liver Int. 2023 Jul;43(7):1497-1506. doi: 10.1111/liv.15592. Epub 2023 May 8.

  • Research gaps and opportunities in autoimmune hepatitis-Results of the international autoimmune hepatitis group research workshop 2022.
    Snijders RJALM, Assis DN, Oo YH, Sebode M, Taubert R, Willemse J, Tomsin B, Lohse AW, Drenth JPH, Gevers TJG; International Autoimmune Hepatitis Group (IAIHG) collaborators and the European Reference Network for Rare Liver Diseases (ERN RARE-LIVER).
    Liver Int. 2023 Jul;43(7):1375-1384. doi: 10.1111/liv.15573. Epub 2023 Apr 10.

  • Setanaxib, a first-in-class selective NADPH oxidase 1/4 inhibitor for primary biliary cholangitis: A randomized, placebo-controlled, phase 2 trial.
    Invernizzi P, Carbone M, Jones D, Levy C, Little N, Wiesel P, Nevens F; study investigators.
    Liver Int. 2023 Jul;43(7):1507-1522. doi: 10.1111/liv.15596. Epub 2023 May 15.

  • Ursodeoxycholic Acid Treatment-Induced GLOBE Score Changes Are Associated With Liver Transplantation-Free Survival in Patients With Primary Biliary Cholangitis.
    de Veer RC, van Hooff MC, Corpechot C, Thorburn D, Invernizzi P, Lammers WJ, Janssen HLA, Battezzati PM, Nevens F, Lindor KD, Floreani A, Ponsioen CY, Mayo MJ, Parés A, Mason AL, Kowdley KV, Trivedi PJ, Hirschfield GM, Goet JC, Bruns T, Dalekos GN, Gatselis NK, Verhelst X, Hansen BE, Harms MH, van der Meer AJ; Global PBC Study Group.
    Am J Gastroenterol. 2023 Jul 1;118(7):1196-1203. doi: 10.14309/ajg.0000000000002128. Epub 2022 Dec 14.

2023-06

  • Evaluation of immunoserological detection of anti-liver kidney microsomal, anti-soluble liver antigen and anti-mitochondrial antibodies.
    Campos-Murguia A, Henjes N, Loges S, Wedemeyer H, Jaeckel E, Taubert R, Engel B.
    Sci Rep. 2023 Jun 20;13(1):10038. doi: 10.1038/s41598-023-37095-z.

  • Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome.
    Magaz M, Giudicelli-Lett H, Nicoară-Farcău O, Rajoriya N, Goel A, Raymenants K, Hillaire S, Crespo G, Téllez L, Elkrief L, Fondevila C, Orts L, Nery F, Shukla A, Larrue H, Fundora Y, Degroote H, Aguilera V, LLop E, Turco L, Indulti F, Gioia S, Tosetti G, Bitto N, Becchetti C, Alvarado E, Roig C, Diaz R, Praktiknjo M, Konicek AL, Soy G, Olivas P, Fortea JI, Masnou H, Puente Á, Ardèvol A, Álvarez-Navascués C, Romero M, Scheiner B, Semmler G, Mandorfer M, Damião F, Baiges A, Turon F, Simón-Talero M, González-Alayón C, Díaz A, García-Criado Á, de Gottardi A, Reverter E, Blasi A, Genescà J, Roux O, Francoz C, Noronha Ferreira C, Reiberger T, Rodríguez M, Morillas RM, Crespo J, Trebicka J, Bañares R, Villanueva C, Berzigotti A, Primignani M, La Mura V, Riggio O, Schepis F, Procopet B, Verhelst X, Calleja JL, Bureau C, Albillos A, Nevens F, Hernández-Gea V, Tripathi D, Rautou PE, Durand F, García-Pagán JC.
    Transplantation. 2023 Jun 1;107(6):1330-1340. doi: 10.1097/TP.0000000000004444. Epub 2023 May 23.

  • Reply to “Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome”.
    Magaz M, Giudicelli-Lett H, Rautou PE, Durand F, García-Pagán JC.
    Transplantation. 2023 Jun 1;107(6):e187. doi: 10.1097/TP.0000000000004611. Epub 2023 May 23.

2023-05

  • Long-term outcomes of patients with type 1 or 2 autoimmune hepatitis presenting in childhood.
    Maggiore G, Bernard O, Mosca A, Ballot E, Johanet C, Jacquemin E.
    J Hepatol. 2023 May;78(5):979-988. doi: 10.1016/j.jhep.2023.01.013. Epub 2023 Jan 25.

  • Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort study.
    Sonneveld MJ, Chiu SM, Park JY, Brakenhoff SM, Kaewdech A, Seto WK, Tanaka Y, Carey I, Papatheodoridi M, Colombatto P, van Bömmel F, Berg T, Zoulim F, Ahn SH, Dalekos GN, Erler NS, Brunetto M, Wedemeyer H, Cornberg M, Yuen MF, Agarwal K, Boonstra A, Buti M, Piratvisuth T, Papatheodoridis G, Chen CH, Maasoumy B; CREATE study group.
    JHEP Rep. 2023 May 12;5(8):100790. doi: 10.1016/j.jhepr.2023.100790. eCollection 2023 Aug.

  • Paediatric autoimmune hepatitis: Time to change the textbooks?
    Lohse AW, Hørby Jørgensen M.
    J Hepatol. 2023 May;78(5):893-895. doi: 10.1016/j.jhep.2023.02.017. Epub 2023 Feb 24.

2023-04

  • COVID-19 in patients with neuroendocrine neoplasms: 2-year results of the INTENSIVE study.
    Fazio N, Gervaso L, Halfdanarson TR, Sonbol M, Eiring RA, Pusceddu S, Prinzi N, Lombardi Stocchetti B, Grozinsky-Glasberg S, Gross DJ, Walter T, Robelin P, Lombard-Bohas C, Frassoni S, Bagnardi V, Antonuzzo L, Sparano C, Massironi S, Gelsomino F, Bongiovanni A, Ranallo N, Tafuto S, Rossi M, Cives M, Rasul Kakil I, Hamid H, Chirco A, Squadroni M, La Salvia A, Hernando J, Hofland J, Koumarianou A, Boselli S, Tamayo D, Mazzon C, Rubino M, Spada F.
    Endocr Relat Cancer. 2023 Apr 26;30(6):e220395. doi: 10.1530/ERC-22-0395. Print 2023 Jun 1.

  • Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis.
    Thompson RJ, Artan R, Baumann U, Calvo PL, Czubkowski P, Dalgic B, D’Antiga L, Di Giorgio A, Durmaz Ö, Gonzalès E, Grammatikopoulos T, Gupte G, Hardikar W, Houwen RHJ, Kamath BM, Karpen SJ, Lacaille F, Lachaux A, Lainka E, Loomes KM, Mack CL, Mattsson JP, McKiernan P, Ni Q, Özen H, Rajwal SR, Roquelaure B, Shteyer E, Sokal E, Sokol RJ, Soufi N, Sturm E, Tessier ME, van der Woerd WL, Verkade HJ, Vittorio JM, Wallefors T, Warholic N, Yu Q, Horn P, Kjems L.
    JHEP Rep. 2023 Apr 29;5(8):100782. doi: 10.1016/j.jhepr.2023.100782. eCollection 2023 Aug.

  • Primary Budd-Chiari Syndrome.
    Garcia-Pagán JC, Valla DC.
    N Engl J Med. 2023 Apr 6;388(14):1307-1316. doi: 10.1056/NEJMra2207738.

  • Salvage therapies of autoimmune hepatitis limit proinflammatory immune cells while sparing regulatory T cells
    Finn C. Derben, Henriette Ytting, Björn Hartleben, Heike Bantel, Heiner Wedemeyer, Gro L. Willemoe, Elmar Jaeckel, Richard Taubert
    Hepatol Commun. 2023 Apr; 7(4): e0088. Published online 2023 Mar 24. doi: 10.1097/HC9.0000000000000088

  • Treatment responses and outcomes in patients with autoimmune hepatitis and concomitant features of non-alcoholic fatty liver disease.
    Zachou K, Azariadis K, Lytvyak E, Snijders RJALM, Takahashi A, Gatselis NK, Robles M, Andrade RJ, Schramm C, Lohse AW, Tanaka A, Drenth JPH, Montano-Loza AJ, Dalekos GN; International Autoimmune Hepatitis Group (IAIHG).
    JHEP Rep. 2023 Apr 22;5(8):100778. doi: 10.1016/j.jhepr.2023.100778. eCollection 2023 Aug.

2023-03

  • Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial
    David Jones, Marco Carbone, Pietro Invernizzi, Nicola Little, Frederik Nevens, Mark G. Swain, Philippe Wiesel, Cynthia Levy
    Hepatol Commun. 2023 Mar; 7(3): e0057. Published online 2023 Feb 20. doi: 10.1097/HC9.0000000000000057

  • Salvage therapies of autoimmune hepatitis limit proinflammatory immune cells while sparing regulatory T cells.
    Derben FC, Ytting H, Hartleben B, Bantel H, Wedemeyer H, Willemoe GL, Jaeckel E, Taubert R.
    Hepatol Commun. 2023 Mar 24;7(4):e0088. doi: 10.1097/HC9.0000000000000088. eCollection 2023 Apr 1.

2023-02

  • Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis.
    Reiniš J, Petrenko O, Simbrunner B, Hofer BS, Schepis F, Scoppettuolo M, Saltini D, Indulti F, Guasconi T, Albillos A, Téllez L, Villanueva C, Brujats A, Garcia-Pagan JC, Perez-Campuzano V, Hernández-Gea V, Rautou PE, Moga L, Vanwolleghem T, Kwanten WJ, Francque S, Trebicka J, Gu W, Ferstl PG, Gluud LL, Bendtsen F, Møller S, Kubicek S, Mandorfer M, Reiberger T.
    J Hepatol. 2023 Feb;78(2):390-400. doi: 10.1016/j.jhep.2022.09.012. Epub 2022 Sep 22.

  • Confidence in treatment is contributing to quality of life in autoimmune liver diseases. The results of ERN RARE-LIVER online survey.
    Wunsch E, Krause L, Gevers TJ, Schramm C, Janik MK, Krawczyk M, Willemse J, Uhlenbusch N, Löwe B, Lohse AW, Milkiewicz P.
    Liver Int. 2023 Feb;43(2):381-392. doi: 10.1111/liv.15440. Epub 2022 Oct 3.

  • Diagnosis and management of autoimmune hepatitis.
    Muratori L, Lohse AW, Lenzi M.
    BMJ. 2023 Feb 6;380:e070201. doi: 10.1136/bmj-2022-070201.

  • Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trial.
    Akinosoglou K, Kotsaki A, Gounaridi IM, Christaki E, Metallidis S, Adamis G, Fragkou A, Fantoni M, Rapti A, Kalomenidis I, Chrysos G, Boni G, Kainis I, Alexiou Z, Castelli F, Serino FS, Bakakos P, Nicastri E, Tzavara V, Safarika A, Ioannou S, Dagna L, Dimakou K, Tzatzagou G, Chini M, Bassetti M, Kotsis V, Angheben A, Tsoukalas G, Selmi C, Spiropoulou OM, Samarkos M, Doumas M, Damoraki G, Masgala A, Papanikolaou I, Argyraki A, Negri M, Leventogiannis K, Sympardi S, Gatselis NK, Petrakis V, Netea MG, Panagopoulos P, Sakka V, Milionis H, Dalekos GN, Giamarellos-Bourboulis EJ.
    EClinicalMedicine. 2023 Feb;56:101785. doi: 10.1016/j.eclinm.2022.101785. Epub 2022 Dec 26.

  • Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial.
    Jones D, Carbone M, Invernizzi P, Little N, Nevens F, Swain MG, Wiesel P, Levy C.
    Hepatol Commun. 2023 Feb 20;7(3):e0057. doi: 10.1097/HC9.0000000000000057. eCollection 2023 Mar 1.

  • Natural history of liver disease in a large international cohort of children with Alagille syndrome: Results from the GALA study.
    Vandriel SM, Li LT, She H, Wang JS, Gilbert MA, Jankowska I, Czubkowski P, Gliwicz-Miedzińska D, Gonzales EM, Jacquemin E, Bouligand J, Spinner NB, Loomes KM, Piccoli DA, D’Antiga L, Nicastro E, Sokal É, Demaret T, Ebel NH, Feinstein JA, Fawaz R, Nastasio S, Lacaille F, Debray D, Arnell H, Fischler B, Siew S, Stormon M, Karpen SJ, Romero R, Kim KM, Baek WY, Hardikar W, Shankar S, Roberts AJ, Evans HM, Jensen MK, Kavan M, Sundaram SS, Chaidez A, Karthikeyan P, Sanchez MC, Cavalieri ML, Verkade HJ, Lee WS, Squires JE, Hajinicolaou C, Lertudomphonwanit C, Fischer RT, Larson-Nath C, Mozer-Glassberg Y, Arikan C, Lin HC, Bernabeu JQ, Alam S, Kelly DA, Carvalho E, Ferreira CT, Indolfi G, Quiros-Tejeira RE, Bulut P, Calvo PL, Önal Z, Valentino PL, Desai DM, Eshun J, Rogalidou M, Dezsőfi A, Wiecek S, Nebbia G, Pinto RB, Wolters VM, Tamara ML, Zizzo AN, Garcia J, Schwarz K, Beretta M, Sandahl TD, Jimenez-Rivera C, Kerkar N, Brecelj J, Mujawar Q, Rock N, Busoms CM, Karnsakul W, Lurz E, Santos-Silva E, Blondet N, Bujanda L, Shah U, Thompson RJ, Hansen BE, Kamath BM; Global ALagille Alliance (GALA) Study Group.
    Hepatology. 2023 Feb 1;77(2):512-529. doi: 10.1002/hep.32761. Epub 2022 Oct 13.

  • Primary biliary cholangitis as a roadmap for the development of novel treatments for cholestatic liver diseases†.
    Nevens F, Trauner M, Manns MP.
    J Hepatol. 2023 Feb;78(2):430-441. doi: 10.1016/j.jhep.2022.10.007. Epub 2022 Oct 20.

2023-01

  • Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver Transplantation
    Paolo Angelo Cortesi, Raffaella Viganò, Sara Conti, Ilaria Lenci, Riccardo Volpes, Silvia Martini, Mario Angelico, James Fung, Maria Buti, Audrey Coilly, Francois Durand, Constantino Fondevila, Pascal Lebray, Frederik Nevens, Wojciech G. Polak, Mario Rizzetto, Fabien Zoulim, Giovanni Perricone, Marina Berenguer, Lorenzo Giovanni Mantovani, Christophe Duvoux, Luca Saverio Belli
    Transpl Int. 2023; 36: 10954. Published online 2023 Jan 30. doi: 10.3389/ti.2023.10954

  • Fibrosis-Related Gene Profiling in Liver Biopsies of PiZZ α1-Antitrypsin Children with Different Clinical Courses.
    Kamp JC, Kappe NN, Moro CF, Fuge J, Kuehnel MP, Wrenger S, Welte T, Hoek BV, Jonigk DD, Khedoe PPSJ, Strnad P, Björnstedt M, Stolk J, Janciauskiene S, Nemeth A.
    Int J Mol Sci. 2023 Jan 27;24(3):2485. doi: 10.3390/ijms24032485.

  • Incidence of Isolated Biliary Atresia during the COVID Lockdown in Europe: Results from a Collaborative Project by RARE-Liver.
    Nomden M, Alizai NK, Betalli P, Bruggink JLM, Cananzi M, Christensen VB, D’Antiga L, Davenport M, Fischler B, Hindemith L, Hukkinen M, Johansen LS, de Kleine RH, Madadi-Sanjani O, Ong EGP, Pakarinen MP, Petersen C, Ruiz M, Schunn M, Sturm E, Verkade HJ, Wildhaber BE, Hulscher JBF, On Behalf Of Members Of The Biliary Atresia And Related Disorders Bard Community The ERN RARE-LIVER.
    J Clin Med. 2023 Jan 18;12(3):775. doi: 10.3390/jcm12030775.

2022

  • Genotype-phenotype relationships of truncating mutations, p.E297G and p.D482G in bile salt export pump deficiency.
    Felzen A, van Wessel DBE, Gonzales E, Thompson RJ, Jankowska I, Shneider BL, Sokal E, Grammatikopoulos T, Kadaristiana A, Jacquemin E, Spraul A, Lipiński P, Czubkowski P, Rock N, Shagrani M, Broering D, Nicastro E, Kelly D, Nebbia G, Arnell H, Fischler B, Hulscher JBF, Serranti D, Arikan C, Polat E, Debray D, Lacaille F, Goncalves C, Hierro L, Muñoz Bartolo G, Mozer-Glassberg Y, Azaz A, Brecelj J, Dezsőfi A, Calvo PL, Grabhorn E, Hartleif S, van der Woerd WJ, Kamath BM, Wang JS, Li L, Durmaz Ö, Kerkar N, Jørgensen MH, Fischer R, Jimenez-Rivera C, Alam S, Cananzi M, Laverdure N, Ferreira CT, Guerrero FO, Wang H, Sency V, Kim KM, Chen HL, de Carvalho E, Fabre A, Bernabeu JQ, Zellos A, Alonso EM, Sokol RJ, Suchy FJ, Loomes KM, McKiernan PJ, Rosenthal P, Turmelle Y, Horslen S, Schwarz K, Bezerra JA, Wang K, Hansen BE, Verkade HJ; NAtural course and Prognosis of PFIC and Effect of biliary Diversion (NAPPED) Consortium.
    JHEP Rep. 2022 Nov 16;5(2):100626. doi: 10.1016/j.jhepr.2022.100626. eCollection 2023 Feb.

  • Histological and serological features of acute liver injury after SARS-CoV-2 vaccination.
    Codoni G, Kirchner T, Engel B, Villamil AM, Efe C, Stättermayer AF, Weltzsch JP, Sebode M, Bernsmeier C, Lleo A, Gevers TJ, Kupčinskas L, Castiella A, Pinazo J, De Martin E, Bobis I, Sandahl TD, Pedica F, Invernizzi F, Del Poggio P, Bruns T, Kolev M, Semmo N, Bessone F, Giguet B, Poggi G, Ueno M, Jang H, Elpek GÖ, Soylu NK, Cerny A, Wedemeyer H, Vergani D, Mieli-Vergani G, Lucena MI, Andrade RJ, Zen Y, Taubert R, Terziroli Beretta-Piccoli B.
    JHEP Rep. 2022 Oct 13;5(1):100605. doi: 10.1016/j.jhepr.2022.100605. eCollection 2023 Jan.

  • Acute hepatitis after COVID-19 vaccine: case series by the International autoimmune hepatitis group (IAIHG) and the european reference network on hepatological diseases (ERN RARE-LIVER) Greta Codoni, Maria Alejandra Gracia Villamil, Albert Stättermayer, Agustin Castiella, Christoph Schramm, Jan-Philipp Weltzsch, Marcial Sebode, Christine Bernsmeier, Wikrom Karnsakul, Ana Lleo, Tom Gevers, Limas Kupcinskas, Nélia Hernandez, Andreas Cerny, Michele Ghielmetti, Diego Vergani, Giorgina Mieli-Vergani, Jose Pinazo Bandera, Maria Isabel Lucena, Raul J. Andrade, Yoh Zen, Richard Taubert
    J Hepatol. 2022 Jul; 77: S308–S309. Published online 2022 Jul 4. doi: 10.1016/S0168-8278(22)00984-9

  • Biliary Atresia in 2021: Epidemiology, Screening and Public Policy
    by Richard A. Schreiber 1,*ORCID,Sanjiv Harpavat 2,Jan B. F. Hulscher 3,† and Barbara E. Wildhaber 4ORCID
    J. Clin. Med. 2022, 11(4), 999; https://doi.org/10.3390/jcm11040999

  • Children with autoimmune liver disease have limited access to age-appropriate drug formulations, results from a European survey
    Marianne Hørby Jørgensen 1, Mara Cananzi 2, Gustav Buescher 3, Marianne Samyn 4, Ruth De Bruyne 5
    PMID: 35523356 DOI: 10.1016/j.jhep.2022.04.025

  • Cholangitis Definition and Treatment after Kasai Hepatoportoenterostomy for Biliary Atresia: A Delphi Process and International Expert Panel
    Ana M Calinescu 1, Omid Madadi-Sanjani 2, Cara Mack 3, Richard A Schreiber 4, Riccardo Superina 5, Deirdre Kelly 6, Claus Petersen 2, Barbara E Wildhaber 1
    PMID: 35159946 PMCID: PMC8836553 DOI: 10.3390/jcm11030494

  • Contrast‐enhanced CT and liver surface nodularity for the diagnosis of porto‐sinusoidal vascular disorder: A case‐control study
    Shantha Ram Valainathan, Riccardo Sartoris, Laure Elkrief, Marta Magaz, Fabian Betancourt, Silvia Pellegrino, Arianna Nivolli, Marco Dioguardi Burgio, Yves Flattet, Sylvain Terraz, Nicolas Drilhon, Marie Lazareth, Julia Herrou, Onorina Bruno, Audrey Payance, Aurélie Plessier, François Durand, Maxime Ronot, Dominique‐Charles Valla, Valérie Paradis, Juan Carlos Garcia‐Pagan, Valérie Vilgrain, Pierre‐Emmanuel Rautou
    Hepatology. 2022 Aug; 76(2): 418–428. Published online 2022 Feb 16. doi: 10.1002/hep.32367

  • Controversies in Choledochal Malformation in Children: An International Survey among Pediatric Hepatobiliary Surgeons and Gastroenterologists Jan B. F. Hulscher, Joachim F. Kuebler, Janneke M. Bruggink, Mark Davenport, Stefan Scholz, Claus Petersen, Omid Madadi-Sanjani, Nagoud Schukfeh J Clin Med. 2022 Feb; 11(4): 1148. Published online 2022 Feb 21. doi: 10.3390/jcm11041148

  • Detailed stratified GWAS analysis for severe COVID-19 in four European populations
    Frauke Degenhardt, David Ellinghaus, Simonas Juzenas, Jon Lerga-Jaso, Mareike Wendorff, Douglas Maya-Miles, Florian Uellendahl-Werth, Hesham ElAbd, Malte C Rühlemann, Jatin Arora, Onur Özer, Ole Bernt Lenning, Ronny Myhre, May Sissel Vadla, Eike M Wacker, Lars Wienbrandt, Aaron Blandino Ortiz, Adolfo de Salazar, Adolfo Garrido Chercoles, Adriana Palom, Agustín Ruiz, Alba-Estela Garcia-Fernandez, Albert Blanco-Grau, Alberto Mantovani, Alberto Zanella, Aleksander Rygh Holten, Alena Mayer, Alessandra Bandera, Alessandro Cherubini, Alessandro Protti, Alessio Aghemo, Alessio Gerussi, Alfredo Ramirez, Alice Braun, Almut Nebel, Ana Barreira, Ana Lleo, Ana Teles, Anders Benjamin Kildal, Andrea Biondi, Andrea Caballero-Garralda, Andrea Ganna, Andrea Gori, Andreas Glück, Andreas Lind, Anja Tanck, Anke Hinney, Anna Carreras Nolla, Anna Ludovica Fracanzani, Anna Peschuck, Annalisa Cavallero, Anne Ma Dyrhol-Riise, Antonella Ruello, Antonio Julià, Antonio Muscatello, Antonio Pesenti, Antonio Voza, Ariadna Rando-Segura, Aurora Solier, Axel Schmidt, Beatriz Cortes, Beatriz Mateos, Beatriz Nafria-Jimenez, Benedikt Schaefer, Björn Jensen, Carla Bellinghausen, Carlo Maj, Carlos Ferrando, Carmen de la Horra, Carmen Quereda, Carsten Skurk, Charlotte Thibeault, Chiara Scollo, Christian Herr, Christoph D Spinner, Christoph Gassner, Christoph Lange, Cinzia Hu, Cinzia Paccapelo, Clara Lehmann, Claudio Angelini, Claudio Cappadona, Clinton Azuure, COVICAT study group, Aachen Study (COVAS), Cristiana Bianco, Cristina Cea, Cristina Sancho, Dag Arne Lihaug Hoff, Daniela Galimberti, Daniele Prati, David Haschka, David Jiménez, David Pestaña, David Toapanta, Eduardo Muñiz-Diaz, Elena Azzolini, Elena Sandoval, Eleonora Binatti, Elio Scarpini, Elisa T Helbig, Elisabetta Casalone, Eloisa Urrechaga, Elvezia Maria Paraboschi, Emanuele Pontali, Enric Reverter, Enrique J Calderón, Enrique Navas, Erik Solligård, Ernesto Contro, Eunate Arana-Arri, Fátima Aziz, Federico Garcia, Félix García Sánchez, Ferruccio Ceriotti, Filippo Martinelli-Boneschi, Flora Peyvandi, Florian Kurth, Francesco Blasi, Francesco Malvestiti, Francisco J Medrano, Francisco Mesonero, Francisco Rodriguez-Frias, Frank Hanses, Fredrik Müller, Georg Hemmrich-Stanisak, Giacomo Bellani, Giacomo Grasselli, Gianni Pezzoli, Giorgio Costantino, Giovanni Albano, Giulia Cardamone, Giuseppe Bellelli, Giuseppe Citerio, Giuseppe Foti, Giuseppe Lamorte, Giuseppe Matullo, Guido Baselli, Hayato Kurihara, Holger Neb, Ilaria My, Ingo Kurth, Isabel Hernández, Isabell Pink, Itziar de Rojas, Iván Galván-Femenia, Jan Cato Holter, Jan Egil Afset, Jan Heyckendorf, Jan Kässens, Jan Kristian Damås, Jan Rybniker, Janine Altmüller, Javier Ampuero, Javier Martín, Jeanette Erdmann, Jesus M Banales, Joan Ramon Badia, Joaquin Dopazo, Jochen Schneider, Jonas Bergan, Jordi Barretina, Jörn Walter, Jose Hernández Quero, Josune Goikoetxea, Juan Delgado, Juan M Guerrero, Julia Fazaal, Julia Kraft, Julia Schröder, Kari Risnes, Karina Banasik, Karl Erik Müller, Karoline I Gaede, Koldo Garcia-Etxebarria, Kristian Tonby, Lars Heggelund, Laura Izquierdo-Sanchez, Laura Rachele Bettini, Lauro Sumoy, Leif Erik Sander, Lena J Lippert, Leonardo Terranova, Lindokuhle Nkambule, Lisa Knopp, Lise Tuset Gustad, Lucia Garbarino, Luigi Santoro, Luis Téllez, Luisa Roade, Mahnoosh Ostadreza, Maider Intxausti, Manolis Kogevinas, Mar Riveiro-Barciela, Marc M Berger, Marco Schaefer, Mari E K Niemi, María A Gutiérrez-Stampa, Maria Carrabba, Maria E Figuera Basso, Maria Grazia Valsecchi, María Hernandez-Tejero, Maria J G T Vehreschild, Maria Manunta, Marialbert Acosta-Herrera, Mariella D’Angiò, Marina Baldini, Marina Cazzaniga, Marit M Grimsrud, Markus Cornberg, Markus M Nöthen, Marta Marquié, Massimo Castoldi, Mattia Cordioli, Maurizio Cecconi, Mauro D’Amato, Max Augustin, Melissa Tomasi, Mercè Boada, Michael Dreher, Michael J Seilmaier, Michael Joannidis, Michael Wittig, Michela Mazzocco, Michele Ciccarelli, Miguel Rodríguez-Gandía, Monica Bocciolone, Monica Miozzo, Natale Imaz Ayo, Natalia Blay, Natalia Chueca, Nicola Montano, Nicole Braun, Nicole Ludwig, Nikolaus Marx, Nilda Martínez, Norwegian SARS-CoV-2 Study group, Oliver A Cornely, Oliver Witzke, Orazio Palmieri, Pa Study Group, Paola Faverio, Paoletta Preatoni, Paolo Bonfanti, Paolo Omodei, Paolo Tentorio, Pedro Castro, Pedro M Rodrigues, Pedro Pablo España, Per Hoffmann, Philip Rosenstiel, Philipp Schommers, Phillip Suwalski, Raúl de Pablo, Ricard Ferrer, Robert Bals, Roberta Gualtierotti, Rocío Gallego-Durán, Rosa Nieto, Rossana Carpani, Rubén Morilla, Salvatore Badalamenti, Sammra Haider, Sandra Ciesek, Sandra May, Sara Bombace, Sara Marsal, Sara Pigazzini, Sebastian Klein, Serena Pelusi, Sibylle Wilfling, Silvano Bosari, Sonja Volland, Søren Brunak, Soumya Raychaudhuri, Stefan Schreiber, Stefanie Heilmann-Heimbach, Stefano Aliberti, Stephan Ripke, Susanne Dudman, Tanja Wesse, Tenghao Zheng, The STORM Study group, The Humanitas Task Force, The Humanitas Gavazzeni Task Force, Thomas Bahmer, Thomas Eggermann, Thomas Illig, Thorsten Brenner, Tomas Pumarola, Torsten Feldt, Trine Folseraas, Trinidad Gonzalez Cejudo, Ulf Landmesser, Ulrike Protzer, Ute Hehr, Valeria Rimoldi, Valter Monzani, Vegard Skogen, Verena Keitel, Verena Kopfnagel, Vicente Friaza, Victor Andrade, Victor Moreno, Wolfgang Albrecht, Wolfgang Peter, Wolfgang Poller, Xavier Farre, Xiaoli Yi, Xiaomin Wang, Yascha Khodamoradi, Zehra Karadeniz, Anna Latiano, Siegfried Goerg, Petra Bacher, Philipp Koehler, Florian Tran, Heinz Zoller, Eva C Schulte, Bettina Heidecker, Kerstin U Ludwig, Javier Fernández, Manuel Romero-Gómez, Agustín Albillos, Pietro Invernizzi, Maria Buti, Stefano Duga, Luis Bujanda, Johannes R Hov, Tobias L Lenz, Rosanna Asselta, Rafael de Cid, Luca Valenti, Tom H Karlsen, Mario Cáceres, Andre Franke
    Hum Mol Genet. 2022 Dec 1; 31(23): 3945–3966. Published online 2022 Jul 15. doi: 10.1093/hmg/ddac158

  • Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trial
    Karolina Akinosoglou, Antigone Kotsaki, Ioanna-Maria Gounaridi, Eirini Christaki, Simeon Metallidis, Georgios Adamis, Archontoula Fragkou, Massimo Fantoni, Aggeliki Rapti, Ioannis Kalomenidis, Georgios Chrysos, Gloria Boni, Ilias Kainis, Zoi Alexiou, Francesco Castelli, Francesco Saverio Serino, Petros Bakakos, Emanuele Nicastri, Vassiliki Tzavara, Asimina Safarika, Sofia Ioannou, Lorenzo Dagna, Katerina Dimakou, Glykeria Tzatzagou, Maria Chini, Matteo Bassetti, Vasileios Kotsis, Andrea Angheben, George Tsoukalas, Carlo Selmi, Olga-Maria Spiropoulou, Michael Samarkos, Michael Doumas, Georgia Damoraki, Aikaterini Masgala, Ilias Papanikolaou, Aikaterini Argyraki, Marcantonio Negri, Konstantinos Leventogiannis, Styliani Sympardi, Nikolaos K. Gatselis, Vasileios Petrakis, Mihai G. Netea, Periklis Panagopoulos, Vissaria Sakka, Haralampos Milionis, George N. Dalekos, Evangelos J. Giamarellos-Bourboulis
    eClinicalMedicine. 2023 Feb; 56: 101785. Published online 2022 Dec 26. doi: 10.1016/j.eclinm.2022.101785

  • Genotype-phenotype relationships of truncating mutations, p.E297G and p.D482G in bile salt export pump deficiency Antonia Felzen, Daan B.E. van Wessel, Emmanuel Gonzales, Richard J. Thompson, Irena Jankowska, Benjamin L. Shneider, Etienne Sokal, Tassos Grammatikopoulos, Agustina Kadaristiana, Emmanuel Jacquemin, Anne Spraul, Patryk Lipiński, Piotr Czubkowski, Nathalie Rock, Mohammad Shagrani, Dieter Broering, Emanuele Nicastro, Deirdre Kelly, Gabriella Nebbia, Henrik Arnell, Björn Fischler, Jan B.F. Hulscher, Daniele Serranti, Cigdem Arikan, Esra Polat, Dominique Debray, Florence Lacaille, Cristina Goncalves, Loreto Hierro, Gema Muñoz Bartolo, Yael Mozer-Glassberg, Amer Azaz, Jernej Brecelj, Antal Dezsőfi, Pier Luigi Calvo, Enke Grabhorn, Steffen Hartleif, Wendy J. van der Woerd, Binita M. Kamath, Jian-She Wang, Liting Li, Özlem Durmaz, Nanda Kerkar, Marianne Hørby Jørgensen, Ryan Fischer, Carolina Jimenez-Rivera, Seema Alam, Mara Cananzi, Noemie Laverdure, Cristina Targa Ferreira, Felipe Ordoñez Guerrero, Heng Wang, Valerie Sency, Kyung Mo Kim, Huey-Ling Chen, Elisa de Carvalho, Alexandre Fabre, Jesus Quintero Bernabeu, Aglaia Zellos, Estella M. Alonso, Ronald J. Sokol, Frederick J. Suchy, Kathleen M. Loomes, Patrick J. McKiernan, Philip Rosenthal, Yumirle Turmelle, Simon Horslen, Kathleen Schwarz, Jorge A. Bezerra, Kasper Wang, Bettina E. Hansen, Henkjan J. Verkade, the NAtural course and Prognosis of PFIC and Effect of biliary Diversion (NAPPED) Consortium
    JHEP Rep. 2023 Feb; 5(2): 100626. Published online 2022 Nov 16. doi: 10.1016/j.jhepr.2022.100626

  • Histological and serological features of acute liver injury after SARS-CoV-2 vaccination Greta Codoni, Theresa Kirchner, Bastian Engel, Alejandra Maria Villamil, Cumali Efe, Albert Friedrich Stättermayer, Jan Philipp Weltzsch, Marcial Sebode, Christine Bernsmeier, Ana Lleo, Tom JG. Gevers, Limas Kupčinskas, Agustin Castiella, Jose Pinazo, Eleonora De Martin, Ingrid Bobis, Thomas Damgaard Sandahl, Federica Pedica, Federica Invernizzi, Paolo Del Poggio, Tony Bruns, Mirjam Kolev, Nasser Semmo, Fernando Bessone, Baptiste Giguet, Guido Poggi, Masayuki Ueno, Helena Jang, Gülsüm Özlem Elpek, Neşe Karadağ Soylu, Andreas Cerny, Heiner Wedemeyer, Diego Vergani, Giorgina Mieli-Vergani, M. Isabel Lucena, Raul J. Andrade, Yoh Zen, Richard Taubert, Benedetta Terziroli Beretta-Piccoli
    JHEP Rep. 2023 Jan; 5(1): 100605. Published online 2022 Oct 13. doi: 10.1016/j.jhepr.2022.100605

  • Impact of SARS-CoV-2 Pandemic on Vascular Liver Diseases
    Anna Baiges, Eira Cerda, Caroline Amicone, Luis Téllez, Edilmar Alvarado-Tapias, Angela Puente, Jose Ignacio Fortea, Elba Llop, Filipa Rocha, Lara Orts, Oliva Ros-Fargas, Pamela Vizcarra, Kamal Zekrini, Ould Amara Lounes, Ghiles Touati, Natalia Jiménez-Esquivel, Maria Jose Serrano, Angels Falgà, Marta Magaz, Pol Olivas, Fabian Betancourt, Valeria Perez-Campuzano, Fanny Turon, Audrey Payancé, Odile Goria, Pierre-Emmanuel Rautou, Virginia Hernández-Gea, Candid Villanueva, Agustin Albillos, Aurélie Plessier, Juan-Carlos García-Pagán
    Clin Gastroenterol Hepatol. 2022 Jul; 20(7): 1525–1533.e5. Published online 2021 Dec 27

  • Incidence, Impact and Treatment of Ongoing CMV Infection in Patients with Biliary Atresia in Four European Centres
    Björn Fischler, Piotr Czubkowski, Antal Dezsofi, Ulrika Liliemark, Piotr Socha, Ronald J. Sokol, Jan F. Svensson, Mark Davenport
    J Clin Med. 2022 Feb; 11(4): 945. Published online 2022 Feb 11. doi: 10.3390/jcm11040945

  • Increased Serum Levels of Activated Caspases in Murine and Human Biliary Atresia
    Omid Madadi-Sanjani 1, Gunnar Bohlen 1, Fabian Wehrmann 2, Julia Andruszkow 3, Karim Khelif 1 4, Reinhard von Wasielewski 5, Heike Bantel 6, Claus Petersen 1
    PMID: 34205476 PMCID: PMC8234421 DOI: 10.3390/jcm10122718

  • International registry of congenital porto-systemic shunts: a multi-centre, retrospective and prospective registry of neonates, children and adults with congenital porto-systemic shunts Simona Korff, Khaled Mostaguir, Maurice Beghetti, Lorenzo D’Antiga, Dominique Debray, Stéphanie Franchi-Abella, Emmanuel Gonzales, Florent Guerin, Anne-Lise Hachulla, Virginie Lambert, Periklis Makrythanasis, Nicolas Roduit, Laurent Savale, Marie-Victoire Senat, Joël Spaltenstein, Frank van Steenbeek, Barbara E. Wildhaber, Marcel Zwahlen, Valérie A. McLin Orphanet J Rare Dis. 2022; 17: 284. Published online 2022 Jul 19. doi: 10.1186/s13023-022-02412-8

  • Liver injury after SARS‐CoV‐2 vaccination: Features of immune‐mediated hepatitis, role of corticosteroid therapy and outcome
    Cumali Efe, Anand V. Kulkarni, Benedetta Terziroli Beretta‐Piccoli, Bianca Magro, Albert Stättermayer, Mustafa Cengiz, Daniel Clayton‐Chubb, Craig Lammert, Christine Bernsmeier, Özlem Gül, Fatima Higuera‐de la Tijera, Margarita Anders, Ellina Lytvyak, Mete Akın, Tugrul Purnak, Rodrigo Liberal, Mirta Peralta, Berat Ebik, Serkan Duman, Nurhan Demir, Yasemin Balaban, Álvaro Urzua, Fernando Contreras, Maria Grazia Venturelli, Yılmaz Bilgiç, Adriana Medina, Marcos Girala, Fulya Günşar, Maria‐Carlota Londoño, Theodoros Androutsakos, Ayelen Kisch, Alper Yurci, Fatih Güzelbulut, Yasir Furkan Çağın, Enver Avcı, Murat Akyıldız, Emine Kübra Dindar‐Demiray, Murat Harputluoğlu, Rahul Kumar, Sanjaya K. Satapathy, Manuel Mendizabal, Marcelo Silva, Stefano Fagiuoli, Stuart K. Roberts, Neşe Karadağ Soylu, Ramazan Idilman, Eric M. Yoshida, Aldo J. Montano‐Loza, George N. Dalekos, Ezequiel Ridruejo, Thomas D. Schiano, Staffan Wahlin
    Hepatology. 2022 Jun 23 : 10.1002/hep.32572. doi: 10.1002/hep.32572 [Epub ahead of print]

  • Liver transplant‐free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid
    Rozanne C. de Veer, Maren H. Harms, Christophe Corpechot, Douglas Thorburn, Pietro Invernizzi, Harry L. A. Janssen, Pier M. Battezzati, Frederik Nevens, Keith D. Lindor, Annarosa Floreani, Cyriel Y. Ponsioen, Marlyn J. Mayo, Albert Parés, Andrew L. Mason, Kris V. Kowdley, Palak J. Trivedi, Gideon M. Hirschfield, Tony Bruns, George N. Dalekos, Nikolaos K. Gatselis, Xavier Verhelst, Willem J. Lammers, Bettina E. Hansen, Henk R. van Buuren, Adriaan J. van der Meer, the Global PBC Study Group
    Aliment Pharmacol Ther. 2022 Nov; 56(9): 1408–1418. Published online 2022 Sep 22. doi: 10.1111/apt.17226

  • Liver transplant‐free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid
    Rozanne C. de Veer, Maren H. Harms, Christophe Corpechot, Douglas Thorburn, Pietro Invernizzi, Harry L. A. Janssen, Pier M. Battezzati, Frederik Nevens, Keith D. Lindor, Annarosa Floreani, Cyriel Y. Ponsioen, Marlyn J. Mayo, Albert Parés, Andrew L. Mason, Kris V. Kowdley, Palak J. Trivedi, Gideon M. Hirschfield, Tony Bruns, George N. Dalekos, Nikolaos K. Gatselis, Xavier Verhelst, Willem J. Lammers, Bettina E. Hansen, Henk R. van Buuren, Adriaan J. van der Meer, the Global PBC Study Group
    Aliment Pharmacol Ther. 2022 Nov; 56(9): 1408–1418. Published online 2022 Sep 22. doi: 10.1111/apt.17226

  • Natural history of liver disease in a large international cohort of children with Alagille syndrome: Results from the GALA study
    Shannon M. Vandriel, Li‐Ting Li, Huiyu She, Jian‐She Wang, Melissa A. Gilbert, Irena Jankowska, Piotr Czubkowski, Dorota Gliwicz‐Miedzińska, Emmanuel M. Gonzales, Emmanuel Jacquemin, Jérôme Bouligand, Nancy B. Spinner, Kathleen M. Loomes, David A. Piccoli, Lorenzo D’Antiga, Emanuele Nicastro, Étienne Sokal, Tanguy Demaret, Noelle H. Ebel, Jeffrey A. Feinstein, Rima Fawaz, Silvia Nastasio, Florence Lacaille, Dominique Debray, Henrik Arnell, Björn Fischler, Susan Siew, Michael Stormon, Saul J. Karpen, Rene Romero, Kyung Mo Kim, Woo Yim Baek, Winita Hardikar, Sahana Shankar, Amin J. Roberts, Helen M. Evans, M. Kyle Jensen, Marianne Kavan, Shikha S. Sundaram, Alexander Chaidez, Palaniswamy Karthikeyan, Maria Camila Sanchez, Maria Lorena Cavalieri, Henkjan J. Verkade, Way Seah Lee, James E. Squires, Christina Hajinicolaou, Chatmanee Lertudomphonwanit, Ryan T. Fischer, Catherine Larson‐Nath, Yael Mozer‐Glassberg, Cigdem Arikan, Henry C. Lin, Jesus Quintero Bernabeu, Seema Alam, Deirdre A. Kelly, Elisa Carvalho, Cristina Targa Ferreira, Giuseppe Indolfi, Ruben E. Quiros‐Tejeira, Pinar Bulut, Pier Luigi Calvo, Zerrin Önal, Pamela L. Valentino, Dev M. Desai, John Eshun, Maria Rogalidou, Antal Dezsőfi, Sabina Wiecek, Gabriella Nebbia, Raquel Borges Pinto, Victorien M. Wolters, María Legarda Tamara, Andréanne N. Zizzo, Jennifer Garcia, Kathleen Schwarz, Marisa Beretta, Thomas Damgaard Sandahl, Carolina Jimenez‐Rivera, Nanda Kerkar, Jernej Brecelj, Quais Mujawar, Nathalie Rock, Cristina Molera Busoms, Wikrom Karnsakul, Eberhard Lurz, Ermelinda Santos‐Silva, Niviann Blondet, Luis Bujanda, Uzma Shah, Richard J. Thompson, Bettina E. Hansen, Binita M. Kamath, The Global ALagille Alliance (GALA) Study Group Hepatology. 2023 Feb; 77(2): 512–529. Published online 2022 Oct 13. doi: 10.1002/hep.32761

  • No association of serum ferritin levels with advanced liver fibrosis in untreated German patients with autoimmune hepatitis
    Bastian Engel, Elmar Jaeckel, Richard Taubert
    BMC Gastroenterol. 2022; 22: 528. Published online 2022 Dec 19. doi: 10.1186/s12876-022-02588-0

  • Outcome of liver cancer patients with SARS‐CoV‐2 infection: An International, Multicentre, Cohort Study
    Sergio Muñoz‐Martínez, Victor Sapena, Alejandro Forner, Jordi Bruix, Marco Sanduzzi‐Zamparelli, José Ríos, Mohamed Bouattour, Mohamed El‐Kassas, Cassia R. G. Leal, Tudor Mocan, Jean‐Charles Nault, Rogerio C. P. Alves, Helen L. Reeves, Leonardo da Fonseca, Ignacio García‐Juárez, David J. Pinato, María Varela, Saleh A. Alqahtani, Mario R. Alvares‐da‐Silva, Juan C. Bandi, Lorenza Rimassa, Mar Lozano, Jesús M. González Santiago, Frank Tacke, Margarita Sala, María Anders, Anja Lachenmayer, Federico Piñero, Alex França, Maria Guarino, Alessandra Elvevi, Giuseppe Cabibbo, Markus Peck‐Radosavljevic, Ángela Rojas, Mercedes Vergara, Chiara Braconi, Sonia Pascual, Christie Perelló, Vivianne Mello, Carlos Rodríguez‐Lope, Juan Acevedo, Rosanna Villani, Clemence Hollande, Valérie Vilgrain, Ahmed Tawheed, Carmem Ferguson Theodoro, Zeno Sparchez, Lorraine Blaise, Daniele E. Viera‐Alves, Robyn Watson, Flair J. Carrilho, Carlos Moctezuma‐Velázquez, Antonio D’Alessio, Massimo Iavarone, Maria Reig
    Liver Int. 2022 Aug; 42(8): 1891–1901. Published online 2022 Jun 23. doi: 10.1111/liv.15320

  • Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitis
    Richard Taubert 1 2, Bastian Engel 1 2, Jana Diestelhorst 1 2, Katharina L Hupa-Breier 1 2, Patrick Behrendt 1 2 3 4, Niklas T Baerlecken 5, Kurt-Wolfram Sühs 6, Maciej K Janik 2 7, Kalliopi Zachou 8 9, Marcial Sebode 2 10, Christoph Schramm 2 10 11, María-Carlota Londoño 2 12, Sarah Habes 13; UK-AIH Consortium; Ye H Oo 2 14 15, Claudine Lalanne 16, Simon Pape 2 17, Maren Schubert 18, Michael Hust 18, Stefan Dübel 18, Mario Thevis 19, Danny Jonigk 20, Julia Beimdiek 21, Falk F R Buettner 21, Joost P H Drenth 2 17, Luigi Muratori 16, David H Adams 2 14 15, Jessica K Dyson 22 23, Amédée Renand 24, Isabel Graupera 2 12, Ansgar W Lohse 2 10, George N Dalekos 8 9, Piotr Milkiewicz 2 7 25, Martin Stangel 6, Benjamin Maasoumy 1 2, Torsten Witte 5, Heiner Wedemeyer 1 2, Michael P Manns 1 2, Elmar Jaeckel 1 2 26
    Hepatology. 2022 Jan;75(1):13-27. doi: 10.1002/hep.32134. Epub 2021 Dec 5.

  • Rare disease education in Europe and beyond: time to act Birute Tumiene, Harm Peters, Bela Melegh, Borut Peterlin, Algirdas Utkus, Natalja Fatkulina, György Pfliegler, Holm Graessner, Sanja Hermanns, Maurizio Scarpa, Jean-Yves Blay, Sharon Ashton, Lucy McKay, Gareth Baynam Orphanet J Rare Dis. 2022; 17: 441. Published online 2022 Dec 19. doi: 10.1186/s13023-022-02527-y

  • Rare disease education in Europe and beyond: time to act Birute Tumiene, Harm Peters, Bela Melegh, Borut Peterlin, Algirdas Utkus, Natalja Fatkulina, György Pfliegler, Holm Graessner, Sanja Hermanns, Maurizio Scarpa, Jean-Yves Blay, Sharon Ashton, Lucy McKay, Gareth Baynam Orphanet J Rare Dis. 2022; 17: 441. Published online 2022 Dec 19. doi: 10.1186/s13023-022-02527-y

  • SARS-CoV-2 in Pediatric Liver Transplant Recipients: The European Experience.
    Buescher G, Sebode M, Marjot T, Webb GJ, Moon AM, Barnes E, Barritt AS 4th, Cananzi M, Lohse AW, Jørgensen MH, McLin V.J Pediatr Gastroenterol Nutr. 2022 Feb 1;74(2):e41-e42. doi: 10.1097/MPG.0000000000003325.PMID: 34654793

  • SARS-CoV-2 infection in patients with autoimmune hepatitis Thomas Marjot, Gustav Buescher, Marcial Sebode, Eleanor Barnes, A. Sidney Barritt, IV, Matthew J. Armstrong, Luke Baldelli, James Kennedy, Carolyn Mercer, Ann-Kathrin Ozga, Christian Casar, Christoph Schramm, contributing Members and Collaborators of ERN RARE-LIVER/COVID-Hep/SECURE-Cirrhosis, Andrew M. Moon, Gwilym J. Webb, Ansgar W. Lohse J Hepatol. 2021 Jun; 74(6): 1335–1343.
    doi: 10.1016/j.jhep.2021.01.021

  • Severe acute hepatitis and acute liver failure of unknown origin in children: a questionnaire-based study within 34 paediatric liver centres in 22 European countries and Israel, April 2022
    Ruben H de Kleine, Willem S Lexmond, Gustav Buescher, Ekkehard Sturm, Deidre Kelly, Ansgar W Lohse, Dominic Lenz, Marianne Hørby Jørgensen, on behalf of the contributors to the survey
    Euro Surveill. 2022 May 12; 27(19): 2200369. doi: 10.2807/1560-7917.ES.2022.27.19.2200369

  • Severe acute hepatitis and acute liver failure of unknown origin in children: a questionnaire-based study within 34 paediatric liver centres in 22 European countries and Israel, April 2022 Ruben H de Kleine, Willem S Lexmond, Gustav Buescher, Ekkehard Sturm, Deidre Kelly, Ansgar W Lohse, Dominic Lenz, Marianne Hørby Jørgensen, on behalf of the contributors to the survey Euro Surveill. 2022 May 12; 27(19): 2200369. doi: 10.2807/1560-7917.ES.2022.27.19.2200369

  • Surgical and Medical Aspects of the Initial Treatment of Biliary Atresia: Position Paper
    by Mark Davenport 1,*ORCID, Omid Madadi-Sanjani 2ORCID, Christophe Chardot 3ORCID,Henkjan J. Verkade 4ORCID, Saul J. Karpen 5 and Claus Petersen 2ORCID J. Clin. Med. 2022, 11(21), 6601; https://doi.org/10.3390/jcm11216601

  • Survey uncovering variations in the management of primary sclerosing cholangitis across Europe Johanna Eliasson, Bobby Lo, Christoph Scramm, Olivier Chazouilleres, Trine Folseraas, Ulrich Beuers, Henriette Ytting JHEP Rep. 2022 Nov; 4(11): 100553. Published online 2022 Aug 14. doi: 10.1016/j.jhepr.2022.100553

  • The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
    Tom H Karlsen 1, Nick Sheron 2, Shira Zelber-Sagi 3, Patrizia Carrieri 4, Geoffrey Dusheiko 5, Elisabetta Bugianesi 6, Rachel Pryke 7, Sharon J Hutchinson 8, Bruno Sangro 9, Natasha K Martin 10, Michele Cecchini 11, Mae Ashworth Dirac 12, Annalisa Belloni 13, Miquel Serra-Burriel 14, Cyriel Y Ponsioen 15, Brittney Sheena 16, Alienor Lerouge 11, Marion Devaux 11, Nick Scott 17, Margaret Hellard 18, Henkjan J Verkade 19, Ekkehard Sturm 20, Giulio Marchesini 21, Hannele Yki-Järvinen 22, Chris D Byrne 23, Giovanni Targher 24, Aviad Tur-Sinai 25, Damon Barrett 26, Michael Ninburg 27, Tatjana Reic 28, Alison Taylor 29, Tim Rhodes 30, Carla Treloar 31, Claus Petersen 32, Christoph Schramm 33, Robert Flisiak 34, Marieta Y Simonova 35, Albert Pares 36, Philip Johnson 37, Alessandro Cucchetti 38, Isabel Graupera 39, Christos Lionis 40, Elisa Pose 41, Núria Fabrellas 42, Ann T Ma 43, Juan M Mendive 44, Vincenzo Mazzaferro 45, Harry Rutter 46, Helena Cortez-Pinto 47, Deirdre Kelly 48, Robyn Burton 49, Jeffrey V Lazarus 50, Pere Ginès 39, Maria Buti 51, Philip N Newsome 52, Patrizia Burra 53, Michael P Manns 54
    PMID: 34863359 DOI: 10.1016/S0140-6736(21)01701-3

  • The portal vein in patients with cirrhosis is not an excessively inflammatory or hypercoagulable vascular bed, a prospective cohort study
    Ellen G Driever 1, Marta Magaz 2 3, Jelle Adelmeijer 1, Fanny Turon 2 3, Anna Baiges 2 3, Pol Olivas 2 3, Valeria Pérez-Campuzano 2 3, Virginia Hernandez-Gea 2 3, Annabel Blasi 4, Juan-Carlos Garcia-Pagan 2 3, Ton Lisman 1
    PMID: 35748022, PMCID: PMC9545607 DOI: 10.1111/jth.15797

  • Variability of Care and Access to Transplantation for Children with Biliary Atresia Who Need a Liver Replacement
    by Jean de Ville de Goyet,Toni Illhardt,Christophe Chardot,Peace N. Dike,Ulrich Baumann,Katherine Brandt,Barbara E. Wildhaber,Mikko Pakarinen,Fabrizio di Francesco,Ekkehard Sturm,Marianna Cornet,Caroline Lemoine,Eva Doreen Pfister,Ana M. Calinescu,Maria Hukkinen,Sanjiv Harpavat,Fabio Tuzzolino andRiccardo Superina
    J. Clin. Med. 2022, 11(8), 2142; https://doi.org/10.3390/jcm11082142 – 12 Apr 2022

2021

  • Combination of Model for End-Stage Liver Disease and Lactate Predicts Death in Patients Treated With Salvage Transjugular Intrahepatic Portosystemic Shunt for Refractory Variceal Bleeding. Walter A, Rudler M, Olivas P, Moga L, Trépo E, Robic MA, Ollivier-Hourmand I, Baiges A, Sutter O, Bouzbib C, Peron JM, Le Pennec V, Ganne-Carrié N, Garcia-Pagán JC, Mallet M, Larrue H, Dao T, Thabut D, Hernández-Gea V, Nault JC, Bureau C, Allaire M; Salvage TIPS Group. Hepatology. 2021 May 21. doi: 10.1002/hep.31913.

  • Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease. Bassegoda O, Olivas P, Turco L, Mandorfer M, Serra-Burriel M, Tellez L, Kwanten W, Laroyenne A, Farcau O, Alvarado E, Moga L, Vuille-Lessard E, Fortea JI, Ibañez L, Tosetti G, Vanwolleghem T, Larrue H, Burgos-Santamaría D, Stefanescu H, Paternostro R, Cippitelli A, Lens S, Augustin S, Llop E, Laleman W, Trebicka J, Chang J, Masnou H, Zipprich A, Miceli F, Semmler G, Forns X, Primignani M, Bañares R, Puente A, Berzigotti A, Rautou PE, Villanueva C, Ginès P, Garcia-Pagan JC, Procopet B, Bureau C, Albillos A, Francque S, Reiberger T, Schepis F, Graupera I, Hernandez-Gea V. Clin Gastroenterol Hepatol. 2021 Oct 21:S1542-3565(21)01136-8. doi: 10.1016/j.cgh.2021.10.023.

  • Defining Primary Sclerosing Cholangitis: Results from an International PSC Study Group consensus process. Ponsioen CY, Assis DN, Boberg KM, Bowlus CL, Deneau M, Thorburn D, Aabakken L, Färkkilä M, Petersen B, Rupp C, Hübscher SG; IPSCSG. Gastroenterology. 2021 Aug 9:S0016-5085(21)03346-1. doi: 10.1053/j.gastro.2021.07.046.

  • Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver disease. Lackner C, Stauber RE, Davies S, Denk H, Dienes HP, Gnemmi V, Guido M, Miquel R, Paradis V, Schirmacher P, Terracciano L, Berghold A, Pregartner G, Binder L, Douschan P, Rainer F, Sygulla S, Jager M, Rautou PE, Bumbu A, Horhat A, Rusu I, Stefanescu H, Detlefsen S, Krag A, Thiele M, Cortez-Pinto H, Moreno C, Gouw ASH, Tiniakos DG. J Hepatol. 2021 Oct;75(4):810-819. doi: 10.1016/j.jhep.2021.05.029.

  • Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data. Nicoară-Farcău O, Han G, Rudler M, Angrisani D, Monescillo A, Torres F, Casanovas G, Bosch J, Lv Y, Thabut D, Fan D, Hernández-Gea V, García-Pagán JC; Preemptive TIPS Individual Data Metanalysis, International Variceal Bleeding Study and Baveno Cooperation Study groups. Gastroenterology. 2021 Jan;160(1):193-205.e10. doi: 10.1053/j.gastro.2020.09.026.

  • Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: Phase 2 study. Baumann U, Sturm E, Lacaille F, Gonzalès E, Arnell H, Fischler B, Jørgensen MH, Thompson RJ, Mattsson JP, Ekelund M, Lindström E, Gillberg PG, Torfgård K, Soni PN. Clin Res Hepatol Gastroenterol. 2021 Sep;45(5):101751. doi: 10.1016/j.clinre.2021.101751.

  • Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study. Gonzales E, Hardikar W, Stormon M, Baker A, Hierro L, Gliwicz D, Lacaille F, Lachaux A, Sturm E, Setchell KDR, Kennedy C, Dorenbaum A, Steinmetz J, Desai NK, Wardle AJ, Garner W, Vig P, Jaecklin T, Sokal EM, Jacquemin E. Lancet. 2021 Oct 30;398(10311):1581-1592. doi: 10.1016/S0140-6736(21)01256-3.

  • Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2021. Spaander MCW, van der Bogt RD, Baron TH, Albers D, Blero D, de Ceglie A, Conio M, Czakó L, Everett S, Garcia-Pagán JC, Ginès A, Jovani M, Repici A, Rodrigues-Pinto E, Siersema PD, Fuccio L, van Hooft JE. Endoscopy. 2021 Jul;53(7):751-762. doi: 10.1055/a-1475-0063.

  • Genetic aspects of adult and pediatric autoimmune hepatitis: A concise review. Engel B, Laschtowitz A, Janik MK, Junge N, Baumann U, Milkiewicz P, Taubert R, Sebode M. Eur J Med Genet. 2021 Jun;64(6):104214. doi: 10.1016/j.ejmg.2021.104214.

  • Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency. Fromme M, Schneider CV, Pereira V, Hamesch K, Pons M, Reichert MC, Benini F, Ellis P, H Thorhauge K, Mandorfer M, Burbaum B, Woditsch V, Chorostowska-Wynimko J, Verbeek J, Nevens F, Genesca J, Miravitlles M, Nuñez A, Schaefer B, Zoller H, Janciauskiene S, Abreu N, Jasmins L, Gaspar R, Liberal R, Macedo G, Mahadeva R, Gomes C, Schneider KM, Trauner M, Krag A, Gooptu B, Thorburn D, Marshall A, Hurst JR, Lomas DA, Lammert F, Gaisa NT, Clark V, Griffiths W, Trautwein C, Turner AM, McElvaney NG, Strnad P. Gut. 2021 Feb 25:gutjnl-2020-323729. doi: 10.1136/gutjnl-2020-323729.

  • Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis. Laschtowitz A, Zachou K, Lygoura V, Pape S, Derben F, Jaeckel E, Oller-Moreno S, Weidemann S, Krech T, Piecha F, Schön G, Liebhoff AM, Al Tarrah M, Heneghan M, Drenth JPH, Dalekos G, Taubert R, Lohse AW, Schramm C. JHEP Rep. 2021 Jun 12;3(4):100321. doi: 10.1016/j.jhepr.2021.100321.

  • Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study. Arab JP, Díaz LA, Baeza N, Idalsoaga F, Fuentes-López E, Arnold J, Ramírez CA, Morales-Arraez D, Ventura-Cots M, Alvarado-Tapias E, Zhang W, Clark V, Simonetto D, Ahn JC, Buryska S, Mehta TI, Stefanescu H, Horhat A, Bumbu A, Dunn W, Attar B, Agrawal R, Haque ZS, Majeed M, Cabezas J, García-Carrera I, Parker R, Cuyàs B, Poca M, Soriano G, Sarin SK, Maiwall R, Jalal PK, Abdulsada S, Higuera-de la Tijera MF, Kulkarni AV, Rao PN, Guerra Salazar P, Skladaný L, Bystrianska N, Prado V, Clemente-Sanchez A, Rincón D, Haider T, Chacko KR, Cairo F, de Sousa Coelho M, Romero GA, Pollarsky FD, Restrepo JC, Castro-Sanchez S, Toro LG, Yaquich P, Mendizabal M, Garrido ML, Narvaez A, Bessone F, Marcelo JS, Piombino D, Dirchwolf M, Arancibia JP, Altamirano J, Kim W, Araujo RC, Duarte-Rojo A, Vargas V, Rautou PE, Issoufaly T, Zamarripa F, Torre A, Lucey MR, Mathurin P, Louvet A, García-Tsao G, González JA, Verna E, Brown RS, Roblero JP, Abraldes JG, Arrese M, Shah VH, Kamath PS, Singal AK, Bataller R. J Hepatol. 2021 Nov;75(5):1026-1033. doi: 10.1016/j.jhep.2021.06.019.

  • Impact of Genotype, Serum Bile Acids, and Surgical Biliary Diversion on Native Liver Survival in FIC1 Deficiency. van Wessel DBE, Thompson RJ, Gonzales E, Jankowska I, Shneider BL, Sokal E, Grammatikopoulos T, Kadaristiana A, Jacquemin E, Spraul A, Lipiński P, Czubkowski P, Rock N, Shagrani M, Broering D, Algoufi T, Mazhar N, Nicastro E, Kelly D, Nebbia G, Arnell H, Fischler B, Hulscher JBF, Serranti D, Arikan C, Debray D, Lacaille F, Goncalves C, Hierro L, Muñoz Bartolo G, Mozer-Glassberg Y, Azaz A, Brecelj J, Dezsőfi A, Luigi Calvo P, Krebs-Schmitt D, Hartleif S, van der Woerd WL, Wang JS, Li LT, Durmaz Ö, Kerkar N, Hørby Jørgensen M, Fischer R, Jimenez-Rivera C, Alam S, Cananzi M, Laverdure N, Ferreira CT, Ordonez F, Wang H, Sency V, Kim KM, Chen HL, Carvalho E, Fabre A, Quintero Bernabeu J, Alonso EM, Sokol RJ, Suchy FJ, Loomes KM, McKiernan PJ, Rosenthal P, Turmelle Y, Rao GS, Horslen S, Kamath BM, Rogalidou M, Karnsakul WW, Hansen B, Verkade HJ. Hepatology. 2021 Mar 5. doi: 10.1002/hep.31787.

  • Impact of SARS-CoV-2 Pandemic on Vascular Liver Diseases. Baiges A, Cerda E, Amicone C, Téllez L, Alvarado-Tapias E, Puente A, Fortea JI, Llop E, Rocha F, Orts L, Ros-Fargas O, Vizcarra P, Zekrini K, Lounes OA, Touati G, Jiménez-Esquivel N, Serrano MJ, Falgà A, Magaz M, Olivas P, Betancourt F, Perez-Campuzano V, Turon F, Payancé A, Goria O, Rautou PE, Hernández-Gea V, Villanueva C, Albillos A, Plessier A, García-Pagán JC. Clin Gastroenterol Hepatol. 2021 Dec 27:S1542-3565(21)01356-2. doi: 10.1016/j.cgh.2021.12.032.

  • Intravenous ketamine and progressive cholangiopathy in COVID-19 patients. Keta-Cov research group. Electronic address: vincent.mallet@aphp.fr; Keta-Cov research group. J Hepatol. 2021 May;74(5):1243-1244. doi: 10.1016/j.jhep.2021.02.007.

  • Management of the major complications of cirrhosis: Beyond guidelines. Garcia-Pagan JC, Francoz C, Montagnese S, Senzolo M, Mookerjee RP. J Hepatol. 2021 Jul;75 Suppl 1:S135-S146. doi: 10.1016/j.jhep.2021.01.027.

  • MARC1 p.A165T variant is associated with decreased markers of liver injury and enhanced antioxidant capacity in autoimmune hepatitis. Janik MK, Smyk W, Kruk B, Szczepankiewicz B, Górnicka B, Lebiedzińska-Arciszewska M, Potes Y, Simões ICM, Weber SN, Lammert F, Więckowski MR, Milkiewicz P, Krawczyk M. Sci Rep. 2021 Dec 23;11(1):24407. doi: 10.1038/s41598-021-03521-3.

  • Measurement of liver and spleen stiffness as complementary methods for assessment of liver fibrosis in autoimmune hepatitis. Janik MK, Kruk B, Szczepankiewicz B, Kostrzewa K, Raszeja-Wyszomirska J, Górnicka B, Lammert F, Milkiewicz P, Krawczyk M. Liver Int. 2021 Feb;41(2):348-356. doi: 10.1111/liv.14726.

  • Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship. Karkucinska-Wieckowska A, Simoes ICM, Kalinowski P, Lebiedzinska-Arciszewska M, Zieniewicz K, Milkiewicz P, Górska-Ponikowska M, Pinton P, Malik AN, Krawczyk M, Oliveira PJ, Wieckowski MR. Eur J Clin Invest. 2021 May 29:e13622. doi: 10.1111/eci.13622.

  • Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study. Efe C, Dhanasekaran R, Lammert C, Ebik B, Higuera-de la Tijera F, Aloman C, Rıza Calışkan A, Peralta M, Gerussi A, Massoumi H, Catana AM, Torgutalp M, Purnak T, Rigamonti C, Gomez Aldana AJ, Khakoo N, Kacmaz H, Nazal L, Frager S, Demir N, Irak K, Ellik ZM, Balaban Y, Atay K, Eren F, Cristoferi L, Batıbay E, Urzua Á, Snijders R, Kıyıcı M, Akyıldız M, Ekin N, Carr RM, Harputluoğlu M, Hatemi I, Mendizabal M, Silva M, Idilman R, Silveira M, Drenth JPH, Assis DN, Björnsson E, Boyer JL, Invernizzi P, Levy C, Schiano TD, Ridruejo E, Wahlin S. Hepatology. 2021 Jun;73(6):2099-2109. doi: 10.1002/hep.31797.

  • Predicting portal thrombosis in cirrhosis: A prospective study of clinical, ultrasonographic and hemostatic factors. Turon F, Driever EG, Baiges A, Cerda E, García-Criado Á, Gilabert R, Bru C, Berzigotti A, Nuñez I, Orts L, Reverter JC, Magaz M, Camprecios G, Olivas P, Betancourt-Sanchez F, Perez-Campuzano V, Blasi A, Seijo S, Reverter E, Bosch J, Borràs R, Hernandez-Gea V, Lisman T, Garcia-Pagan JC. J Hepatol. 2021 Jul 29:S0168-8278(21)01946-2. doi: 10.1016/j.jhep.2021.07.020.

  • Present and future role of endoscopic retrograde cholangiography in primary sclerosing cholangitis. Waldthaler A, Schramm C, Bergquist A. Eur J Med Genet. 2021 Jun;64(6):104231. doi: 10.1016/j.ejmg.2021.104231.

  • Prevalence of COVID-19 in patients with autoimmune liver disease in Europe: A patient-oriented online survey. Zecher BF, Buescher G, Willemse J, Walmsley M, Taylor A, Leburgue A, Schramm C, Lohse AW, Sebode M. United European Gastroenterol J. 2021 Sep;9(7):797-808. doi: 10.1002/ueg2.12100

  • Proximal Splenic Artery Embolization to Treat Refractory Ascites in a Patient With Cirrhosis. Caporali C, Turco L, Prampolini F, Quaretti P, Bianchini M, Saltini D, Miceli F, Casari F, Felaco D, Garcia-Pagan JC, Trebicka J, Senzolo M, Guerrini GP, Di Benedetto F, Torricelli P, Villa E, Schepis F. Hepatology. 2021 Jul 4. doi: 10.1002/hep.32037.

  • Quality of life in patients with primary biliary cholangitis: A cross-geographical comparison. Montali L, Gragnano A, Miglioretti M, Frigerio A, Vecchio L, Gerussi A, Cristoferi L, Ronca V, D’Amato D, O’Donnell SE, Mancuso C, Lucà M, Yagi M, Reig A, Jopson L, Pilar S, Jones D, Pares A, Mells G, Tanaka A, Carbone M, Invernizzi P. J Transl Autoimmun. 2021 Jan 6;4:100081. doi: 10.1016/j.jtauto.2021.100081.

  • Rare variants of primary liver cancer: Fibrolamellar, combined, and sarcomatoid hepatocellular carcinomas. Wege H, Schulze K, von Felden J, Calderaro J, Reig M; rare liver tumors working group of the European Reference Network on Hepatological Diseases (ERN RARE-LIVER). Eur J Med Genet. 2021 Aug 18:104313. doi: 10.1016/j.ejmg.2021.104313.

  • Reply to: “Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered”. Mallet V; Keta-Cov research group. J Hepatol. 2021 Jun 24:S0168-8278(21)00444-X. doi: 10.1016/j.jhep.2021.06.024.

  • Risk of non-tumoural portal vein thrombosis in patients with HCV-induced cirrhosis after sustained virological response. Mandorfer M, Turon F, Lens S, Baiges A, García-Criado Á, Darnell A, Belmonte E, Ferrusquía-Acosta J, Magaz M, Perez-Campuzano V, Olivas P, Bauer D, Casanovas G, Torres F, Mariño Z, Forns X, Hernández-Gea V, García-Pagán JC. Liver Int. 2021 Jul 9. doi: 10.1111/liv.15009.

  • Salvage TIPS in cirrhotic patients with variceal bleeding: MELD, lactates and « à la carte » decision. Allaire M, Garcia-Pagán JC, Walter A, Bureau C, Thabut D. Hepatology. 2021 Aug 5. doi: 10.1002/hep.32091.

  • Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool. Murillo Perez CF, Gulamhusein A, Carbone M, Trivedi PJ, van der Meer AJ, Corpechot C, Battezzati PM, Lammers WJ, Cazzagon N, Floreani A, Parés A, Nevens F, Lleo A, Mayo MJ, Kowdley KV, Ponsioen CY, Dalekos GN, Gatselis NK, Thorburn D, Mason AL, Janssen H, Verhelst X, Bruns T, Lindor KD, Chazouillères O, Invernizzi P, Hansen BE, Hirschfield GM; GLOBAL PBC Study Group. Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e266-e273. doi: 10.1097/MEG.0000000000002029.

  • The concept of rebalanced hemostasis in patients with liver disease: Communication from the ISTH SSC working group on hemostatic management of patients with liver disease. Lisman T, Hernandez-Gea V, Magnusson M, Roberts L, Stanworth S, Thachil J, Tripodi A. J Thromb Haemost. 2021 Apr;19(4):1116-1122. doi: 10.1111/jth.15239.

  • The genetic architecture of primary biliary cholangitis. Gerussi A, Carbone M, Corpechot C, Schramm C, Asselta R, Invernizzi P. Eur J Med Genet. 2021 Sep;64(9):104292. doi: 10.1016/j.ejmg.2021.104292.

  • Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases. Northup PG, Garcia-Pagan JC, Garcia-Tsao G, Intagliata NM, Superina RA, Roberts LN, Lisman T, Valla DC. Hepatology. 2021 Jan;73(1):366-413. doi: 10.1002/hep.31646.

2020

  • 2D shear wave liver elastography by Aixplorer to detect portal hypertension in cirrhosis: An individual patient data meta-analysis. Thiele M, Hugger MB, Kim Y, Rautou PE, Elkrief L, Jansen C, Verlinden W, Allegretti G, Israelsen M, Stefanescu H, Piscaglia F, García-Pagán JC, Franque S, Berzigotti A, Castera L, Jeong WK, Trebicka J, Krag A. Liver Int. 2020 Jun;40(6):1435-1446. doi: 10.1111/liv.14439. Epub 2020 Apr 8.

  • Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis. Ferrusquía-Acosta J, Bassegoda O, Turco L, Reverter E, Pellone M, Bianchini M, Pérez-Campuzano V, Ripoll E, García-Criado Á, Graupera I, García-Pagán JC, Schepis F, Senzolo M, Hernández-Gea V. J Hepatol. 2020 Oct 14:S0168-8278(20)33683-7. doi: 10.1016/j.jhep.2020.10.003.

  • Budd-Chiari syndrome. Coilly A, Potier P, Broué P, Kounis I, Valla D, Hillaire S, Lambert V, Dutheil D, Hernández-Gea V, Plessier A, Vilgrain V, Bureau C. Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):420-425. doi: 10.1016/j.clinre.2020.03.015.

  • Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, Cardinale V, Carpino G, Andersen JB, Braconi C, Calvisi DF, Perugorria MJ, Fabris L, Boulter L, Macias RIR, Gaudio E, Alvaro D, Gradilone SA, Strazzabosco M, Marzioni M, Coulouarn C, Fouassier L, Raggi C, Invernizzi P, Mertens JC, Moncsek A, Rizvi S, Heimbach J, Koerkamp BG, Bruix J, Forner A, Bridgewater J, Valle JW, Gores GJ. Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):557-588. doi: 10.1038/s41575-020-0310-z.

  • Congenital portosystemic shunts: Vascular liver diseases: Position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver. Guérin F, Franchi Abella S, McLin V, Ackermann O, Girard M, Cervoni JP, Savale L, Hernandez-Gea V, Valla D, Hillaire S, Dutheil D, Bureau C, Gonzales E, Plessier A. Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):452-459. doi: 10.1016/j.clinre.2020.03.004.

  • Drug induced liver injury and vascular liver disease. Larrey D, Meunier L, Valla D, Hillaire S, Hernandez-Gea V, Dutheil D, Plessier A, Bureau C. Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):471-479. doi: 10.1016/j.clinre.2020.03.020.

  • Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis. Hedin CRH, Sado G, Ndegwa N, Lytvyak E, Mason A, Montano-Loza A, Gerussi A, Saffioti F, Thorburn D, Nilsson E, Larsson G, Moum BA, van Munster KN, Ponsioen CY, Levy C, Nogueira NF, Bowlus CL, Gotlieb N, Shibolet O, Lynch KD, Chapman RW, Rupp C, Vesterhus M, Jørgensen KK, Rorsman F, Schramm C, Sabino J, Vermeire S, Zago A, Cazzagon N, Marschall HU, Ytting H, Ben Belkacem K, Chazouilleres O, Almer S; International PSC Study Group, Bergquist A. Clin Gastroenterol Hepatol. 2020 Feb 15:S1542-3565(20)30182-8. doi: 10.1016/j.cgh.2020.02.014.

  • Extrahepatic portal vein obstruction (EHPVO) in cirrhosis. Abergel A, Gasperment M, Nery FG, Buchard B, Lebreton A, Hordonneau C, Duron C, Valla D, Sophie H, Ledain-Rautou E, Hernandez-Gea V, Dutheil D, Plessier A, Bureau C, Francoz C. Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):497-502. doi: 10.1016/j.clinre.2020.03.014.

  • Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆. Anstee QM, Darlay R, Cockell S, Meroni M, Govaere O, Tiniakos D, Burt AD, Bedossa P, Palmer J, Liu YL, Aithal GP, Allison M, Yki-Järvinen H, Vacca M, Dufour JF, Invernizzi P, Prati D, Ekstedt M, Kechagias S, Francque S, Petta S, Bugianesi E, Clement K, Ratziu V, Schattenberg JM, Valenti L, Day CP, Cordell HJ, Daly AK; EPoS Consortium Investigators. J Hepatol. 2020 Sep;73(3):505-515. doi: 10.1016/j.jhep.2020.04.003.Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, Cardinale V, Carpino G, Andersen JB, Braconi C, Calvisi DF, Perugorria MJ, Fabris L, Boulter L, Macias RIR, Gaudio E, Alvaro D, Gradilone SA, Strazzabosco M, Marzioni M, Coulouarn C, Fouassier L, Raggi C, Invernizzi P, Mertens JC, Moncsek A, Rizvi S, Heimbach J, Koerkamp BG, Bruix J, Forner A, Bridgewater J, Valle JW, Gores GJ. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):557-588. doi: 10.1038/s41575-020-0310-z.

  • Genotype correlates with the natural history of severe bile salt export pump deficiency. van Wessel DBE, Thompson RJ, Gonzales E, Jankowska I, Sokal E, Grammatikopoulos T, Kadaristiana A, Jacquemin E, Spraul A, Lipiński P, Czubkowski P, Rock N, Shagrani M, Broering D, Algoufi T, Mazhar N, Nicastro E, Kelly D, Nebbia G, Arnell H, Fischler BR, Hulscher JBF, Serranti D, Arikan C, Polat E, Debray D, Lacaille F, Goncalves C, Hierro L, Muñoz Bartolo G, Mozer-Glassberg Y, Azaz A, Brecelj J, Dezsőfi A, Calvo PL, Grabhorn E, Sturm E, van der Woerd WJ, Kamath BM, Wang JS, Li L, Durmaz Ö, Onal Z, Bunt TM, Hansen B, Verkade HJ. J Hepatol. 2020 Feb 19. pii: S0168-8278(20)30105-7. doi: 10.1016/j.jhep.2020.02.007.

  • High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation. Pape S, Gevers TJG, Vrolijk JM, van Hoek B, Bouma G, van Nieuwkerk CMJ, Taubert R, Jaeckel E, Manns MP, Papp M, Sipeki N, Stickel F, Efe C, Ozaslan E, Purnak T, Nevens F, Kessener DJN, Kahraman A, Wedemeyer H, Hartl J, Schramm C, Lohse AW, Heneghan MA, Drenth JPH. Liver Int. 2020 May 14. doi: 10.1111/liv.14513.

  • Immune system and cholangiocytes: A puzzling affair in primary biliary cholangitis. Ronca V, Mancuso C, Milani C, Carbone M, Oo YH, Invernizzi P. J Leukoc Biol. 2020 Aug;108(2):659-671. doi: 10.1002/JLB.5MR0320-200R.

  • Ischemic cholangiopathy: An update. Goria O, Archambeaud I, Lemaitre C, Dutheil D, Plessier A, Rautou PE, Hernandez-Gea V, Valla D. Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):486-490. doi: 10.1016/j.clinre.2020.03.018.

  • Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi*Z Variant of alpha-1 antitrypsin (Pi*MZ vs Pi*ZZ genotype) and Non-carriers. Schneider CV*, Hamesch K*, Gross A, Mandorfer M, Moeller LS, Pereira V, Pons M, Kuca P, Reichert MC, Benini F, Burbaum B, Voss J, Gutberlet M, Woditsch V, Lindhauer C, Fromme M, Kümpers J, Bewersdorf L, Schäfer B, Eslam M, Bals R, Janciauskiene S, Carvão J, Neureiter D, Zhou B, Wöran K, Bantel H, Geier A, Dirrichs T, Stickel F, Teumer A, Verbeek J, Nevens F, Govaere O, Krawczyk M, Roskams T, Haybaeck J, Lurje G, Chorostowska-Wynimko J, Genesca J, Reiberger T, Zoller H, Lammert F, Krag A, George J, Anstee QM, Trauner M, Datz C, Gaisa NT, Denk H, Trautwein C, Aigner E, Strnad P 2020 May 3. Pii: S0016-5085(20)30577-1 * equal contribution. Gastroenterology (2020), doi: https://doi.org/10.1053/j.gastro.2020.04.058.

  • Liver stiffness by transient elastography to detect porto-sinusoidal vascular liver disease with portal hypertension. Elkrief L, Lazareth M, Chevret S, Paradis V, Magaz M, Blaise L, Rubbia-Brandt L, Moga L, Durand F, Payancé A, Plessier A, Chaffaut C, Valla D, Malphettes M, Diaz A, Nault JC, Nahon P, Audureau E, Ratziu V, Castera L, Garcia Pagan JC, Ganne-Carrie N, Rautou PE; ANRS CO12 CirVir group. Hepatology. 2020 Dec 21. doi: 10.1002/hep.31688.

  • Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis. Corpechot C, Chazouillères O, Belnou P, Montano-Loza AJ, Mason A, Ebadi M, Eurich D, Chopra S, Jacob D, Schramm C, Sterneck M, Bruns T, Reuken P, Rauchfuss F, Roccarina D, Thorburn D, Gerussi A, Trivedi P, Hirschfield G, McDowell P, Nevens F, Boillot O, Bosch A, Giostra E, Conti F, Poupon R, Parés A, Reig A, Donato MF, Malinverno F, Floreani A, Russo FP, Cazzagon N, Verhelst X, Goet J, Harms M, van Buuren H, Hansen B, Carrat F, Dumortier J; Global PBC Study Group. J Hepatol. 2020 Sep;73(3):559-565. doi: 10.1016/j.jhep.2020.03.043.

  • Management of anticoagulation in adult patients with chronic parenchymal or vascular liver disease: Vascular liver diseases: Position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver. Ollivier-Hourmand I, Nguyen N, De Gottardi A, Valla D, Hillaire S, Dutheil D, Bureau C, Hernandez-Gea V, De Raucourt E, Plessier A. Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):438-446. doi: 10.1016/j.clinre.2020.03.006.

  • Management of patients with autoimmune liver disease during COVID-19 pandemic. Lleo A, Invernizzi P, Lohse AW, Aghemo A, Carbone M. J Hepatol. 2020 Aug;73(2):453-455. doi: 10.1016/j.jhep.2020.04.002. Epub 2020 Apr 10.

  • Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis. Gerussi A, Bernasconi DP, O’Donnell SE, Lammers WJ, Van Buuren H, Hirschfield G, Janssen H, Corpechot C, Reig A, Pares A, Battezzati PM, Zuin MG, Cazzagon N, Floreani A, Nevens F, Gatselis N, Dalekos G, Mayo MJ, Thorburn D, Bruns T, Mason AL, Verhelst X, Kowdley K, van der Meer A, Niro GA, Beretta-Piccoli BT, Marzioni M, Belli LS, Marra F, Valsecchi MG, Lindor KD, Invernizzi P, Hansen BE, Carbone M. Clin Gastroenterol Hepatol. 2020 Aug 7;S1542-3565(20)31083-1. doi: 10.1016/j.cgh.2020.08.006.

  • Open challenges in the management of autoimmune hepatitis. Gerussi A, Halliday N, Carbone M, Invernizzi P, Thorburn D. Minerva Gastroenterol Dietol. 2020 Dec 3. doi: 10.23736/S1121-421×.20.02805-6.

  • Portal cavernoma or chronic non cirrhotic extrahepatic portal vein obstruction. Elkrief L, Houssel-Debry P, Ackermann O, Franchi-Abella S, Branchereau S, Valla D, Hillaire S, Dutheil D, Plessier A, Hernandez-Gea V, Bureau C. Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):491-496. doi: 10.1016/j.clinre.2020.03.016.

  • Porto-sinusoidal vascular disease. Vascular liver diseases: Position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver. Giudicelli H, Rautou PE, Paradis V, Bedossa P, Goria O, Lambert V, Hernandez-Gea V, Dutheil D, Plessier A, Bureau C, Valla D. Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):447-451. doi: 10.1016/j.clinre.2020.03.005.

  • Pregnancy and vascular liver diseases. Payancé A, Ceccaldi PF, De Raucourt E, Valla D, Hillaire S, Dutheil D, Hernandez-Gea V, Bureau C, Plessier A. Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):433-437. doi: 10.1016/j.clinre.2020.03.007.

  • Rapid Response to Treatment of Autoimmune Hepatitis Associated With Remission at 6 and 12 Months. Pape S, Gevers TJG, Vrolijk JM, van Hoek B, Bouma G, van Nieuwkerk CMJ, Taubert R, Jaeckel E, Manns MP, Papp M, Sipeki N, Stickel F, Efe C, Ozaslan E, Purnak T, Nevens F, Kessener DJN, Kahraman A, Wedemeyer H, Hartl J, Schramm C, Lohse AW, Drenth JPH, Heneghan MA. Clin Gastroenterol Hepatol. 2020 Jun;18(7):1609-1617.e4. doi: 10.1016/j.cgh.2019.11.013. Epub 2019 Nov 9.

  • Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS. Trebicka J, Gu W, Ibáñez-Samaniego L, Hernández-Gea V, Pitarch C, Garcia E, Procopet B, Giráldez Á, Amitrano L, Villanueva C, Thabut D, Silva-Junior G, Martinez J, Genescà J, Bureau C, Llop E, Laleman W, Palazon JM, Castellote J, Rodrigues S, Gluud L, Ferreira CN, Barcelo R, Cañete N, Rodríguez M, Ferlitsch A, Mundi JL, Gronbaek H, Hernández-Guerra M, Sassatelli R, Dell’Era A, Senzolo M, Abraldes JG, Romero-Gómez M, Zipprich A, Casas M, Masnou H, Primignani M, Weiss E, Catalina MV, Erasmus HP, Uschner FE, Schulz M, Brol MJ, Praktiknjo M, Chang J, Krag A, Nevens F, Calleja JL, Robic MA, Conejo I, Albillos A, Rudler M, Alvarado E, Guardascione MA, Tantau M, Bosch J, Torres F, Pavesi M, Garcia-Pagán JC, Jansen C, Bañares R; International Variceal Bleeding Observational Study Group and Baveno Cooperation. J Hepatol. 2020 Nov;73(5):1082-1091. doi: 10.1016/j.jhep.2020.04.024.

  • Recent (non-cirrhotic) extrahepatic portal vein obstruction. Heurgué A, Habes D, Brugel M, Franchi-Abella S, Condat B, Valla D, Hillaire S, Debray D, Hernandez-Gea V, Dutheil D, Plessier A, Bureau C, Payancé A. Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):460-465. doi: 10.1016/j.clinre.2020.03.003.

  • Risk factors for vascular liver diseases: Vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver. Soret J, Debray D, Fontbrune FS, Kiladjian JJ, Saadoun D, Latour RP, Valla D, Hernandez-Gea V, Hillaire S, Dutheil D, Plessier A, Bureau C, De Raucourt E. Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):410-419. doi: 10.1016/j.clinre.2020.03.010.

  • Second-line and Third-line therapy for Autoimmune Hepatitis A position statement from the European Reference Network on Hepatological Diseases and the International Autoimmune Hepatitis Group. Lohse AW, Sebode M, Jørgensen MH, Ytting H, Karlsen TH, Kelly D, Manns MP, Vesterhus M; European Reference Network on Hepatological Diseases (ERN RARE-LIVER) and of the International Autoimmune Hepatitis Group (IAIHG). J Hepatol. 2020 Jul 21:S0168-8278(20)30470-0. doi: 10.1016/j.jhep.2020.07.023. Online ahead of print.

  • Sinusoidal obstruction syndrome. de Lédinghen V, Villate A, Robin M, Decraecker M, Valla D, Hillaire S, Hernandez-Gea V, Dutheil D, Bureau C, Plessier A. Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):480-485. doi: 10.1016/j.clinre.2020.03.019

  • Social and medical support initiatives in vascular liver diseases in France, from child to adult. Plessier A, Gasperment M, Debray D, Brault C, Ollivier-Hourmand I, Dutheil D, Leclercq A, Devictor J, Hernández-Gea V, Le Beux E, Goria O. Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):466-470. doi: 10.1016/j.clinre.2020.03.002.

2019

  • Abdominal Surgery in Patients With Idiopathic Noncirrhotic Portal Hypertension: A Multicenter Retrospective Study. Elkrief L, Ferrusquia-Acosta J, Payancé A, Moga L, Tellez L, Praktiknjo M, Procopet B, Farcau O, De Lédinghen V, Yuldashev R, Tabchouri N, Barbier L, Dumortier J, Menahem B, Magaz M, Hernández-Gea V, Albillos A, Trebicka J, Spahr L, De Gottardi A, Plessier A, Valla D, Rubbia-Brandt L, Toso C, Bureau C, Garcia-Pagan JC, Rautou PE; for VALDIG, an EASL consortium. Hepatology. 2019 Sep;70(3):911-924. doi: 10.1002/hep.30628.

  • Clinical management of autoimmune hepatitis. Pape S, Schramm C, Gevers TJ. United European Gastroenterol J. 2019 Nov;7(9):1156-1163. doi: 10.1177/2050640619872408. Epub 2019 Aug 25. Review.

  • Current knowledge in pathophysiology and management of Budd-Chiari syndrome and non-cirrhotic non-tumoral splanchnic vein thrombosis. Hernández-Gea V, De Gottardi A, Leebeek FWG, Rautou PE, Salem R, Garcia-Pagan JC. J Hepatol. 2019 Jul;71(1):175-199. doi: 10.1016/j.jhep.2019.02.015. Epub 2019 Feb 26. Review.

  • Depression in patients with autoimmune hepatitis: the need for detailed psychiatric assessment. Janik MK, Wunsch E, Moskwa M, Raszeja-Wyszomirska J, Krawczyk M, Milkiewicz P. Pol Arch Intern Med. 2019 Sep 30;129(9):645-647. doi: 10.20452/pamw.14898. Epub 2019 Jul 12.

  • Efficacy of rituximab in difficult-to-manage Autoimmune Hepatitis: Results from the International Autoimmune Hepatitis Group. Than NN, Hodson J, Schmidt-Martin D, Taubert R, Wawman RE, Botter M, Gautam N, Bock K, Jones R, Appanna GD, Godkin A, Montano-Loza AJ, Lammert F, Schramm C, Manns MP, Swain M, Burak KW, Adams DH, Hirschfield GM, Oo YH. JHEP Reports. Nov 2019. Volume 1, Issue 6, Pages 437-445. Doi: 10.1016/j.jhepr.2019.10.005.

  • Liver Fibrosis and Metabolic Alterations in Adults with Alpha-1 Antitrypsin Deficiency Caused by the Pi*ZZ Mutation; Hamesch K, Mandorfer M, Pereira VM, Moeller LS, Pons M, Dolman GE, Reichert MC, Heimes CV, Woditsch V, Voss J, Lindhauer C, Fromme M, Spivak I, Guldiken N, Zhou B, Arslanow A, Schaefer B, Zoller H, Aigner E, Reiberger T, Wetzel M, Siegmund B, Simões C, Gaspar R, Maia L, Costa D, Bento-Miranda M, van Helden J, Yagmur E, Bzdok D, Stolk J, Gleiber W, Knipel V, Windisch W, Mahadeva R, Bals R, Koczulla R, Barrecheguren M, Miravitlles M, Janciauskiene S, Stickel F, Lammert F, Liberal R, Genesca J, Griffiths WJ, Trauner M, Krag A, Trautwein C, Strnad P. Gastroenterology 2019 Sep;157(3):705-719.e18

  • Position statement on access to care in rare liver diseases: advancements of the European reference network (ERN) RARE-LIVER. Bernts LHP, Jones DEJ, Kaatee MM, Lohse AW, Schramm C, Sturm E, Drenth JPH. ORPHANET JOURNAL OF RARE DISEASES. JUL 8, 2019. Doi: 10.1186/s13023-019-1152-z.

  • The challenges of primary biliary cholangitis: What is new and what needs to be done. Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D, Vierling JM, Adams D, Alpini G, Banales JM, Beuers U, Björnsson E, Bowlus C, Carbone M, Chazouillères O, Dalekos G, De Gottardi A, Harada K, Hirschfield G, Invernizzi P, Jones D, Krawitt E, Lanzavecchia A, Lian ZX, Ma X, Manns M, Mavilio D, Quigley EM, Sallusto F, Shimoda S, Strazzabosco M, Swain M, Tanaka A, Trauner M, Tsuneyama K, Zigmond E, Gershwin ME. J Autoimmun. 2019 Dec;105:102328. doi: 10.1016/j.jaut.2019.102328. Epub 2019 Sep 20. Review.

2018

  • Drug holiday in patients with polycystic liver disease treated with somatostatin analogues. van Aerts RMM, Kolkman M, Kievit W, Gevers TJG, Nevens F, Drenth JPH. Therap Adv Gastroenterol. 2018 Oct 3;11:1756284818804784. doi: 10.1177/1756284818804784.

  • Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis. Strnad P, Buch S, Hamesch K, Fischer J, Rosendahl J, Schmelz R, Brueckner S, Brosch M, Heimes CV, Woditsch V, Scholten D, Nischalke HD, Janciauskiene S, Mandorfer M, Trauner M, Way MJ, McQuillin A, Reichert MC, Krawczyk M, Casper M, Lammert F, Braun F, von Schönfels W, Hinz S, Burmeister G, Hellerbrand C, Teufel A, Feldman A, Schattenberg JM, Bantel H, Pathil A, Demir M, Kluwe J, Boettler T, Ridinger M, Wodarz N, Soyka M, Rietschel M, Kiefer F, Weber T, Marhenke S, Vogel A, Hinrichsen H, Canbay A, Schlattjan M, Sosnowsky K, Sarrazin C, von Felden J, Geier A, Deltenre P, Sipos B, Schafmayer C, Nothnagel M, Aigner E, Datz C, Stickel F, Morgan MY, Hampe J, Berg T, Trautwein C. Gut. 2018 Aug 1. pii: gutjnl-2018-316228. doi: 10.1136/gutjnl-2018-316228.